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Preface
In the course or dev�lopment of any chapter

ot medicine, there are periodsJwhen it becomes appro

priate and even necessary to correlate the resulta of

investigation on a particular problem, with the aim
of creating, out ot indiTldual fragments ot �xper1-

ence and research, a unified and meaningt'ul whole.

This necessity is particularly great When

the question under consideration happens to lie in
the realm or therapeutics, tor in this case it la

only through a thorough analysis or the problem that
rational guideposts for future clinical action can
be erected.

And especially When there enters upon

the medical scene a new form of therapy bearing the
possibility or revolutionizing an entire branch or

medicine, a sc1�1fic assessment of.its value be
comes indeed a matter

or

utmost indispensability.

Such ls the case today with the shock
therapies in psychiatry.

Born or chance and empi

ricism, subsequently treated, like many another new
therapeutic agent, with all degrees of reaction

ranging from exuberant enthusiasm to violent condemna- 1 -
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tion, the shock therapies haTe suniTed a decade or

stormy existence am haTe today reached the point

where aut"f1c1ent eTidenee has accumulated to warrant
a rational eTaluation of them.
Because of the cont�oTersy and. contusion
concerning the results obtained with the shock

therapies -- a state of affairs Which has plagued

them eTer since they became subjected to extens1Te

clinical trial

-- some obserTers haTe thrown up

their hands 1n desperation and haTe discredited. them
on this basis alone.

HoweTer, since �Tery effect

has its cause, there are good and ample reasons for
this lack of consensus, and it has been my purpose
in this thesis to sift out these causes of d1�agr�e
ment and to determine, as far as possible, ·the lines
of future approach which will break the impasses
existing today.
I

In this connection, I haTe attempted to

keep these pages from becoming a mere reTiew of the
.•

literature.

Since the literature on any controTersial

question abounds with all shades or opinion and all
degrees of cont'licting eTidence on the topi.e, a mere
listing of sue� eTidence and_op1n1ons, without any
attempt to analyze and eTaluate them, becomes a -·

profitless venture both for the writer and for the
reader.

I have long felt that the most important
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part of the learning process is not what one

but how one's thinking reacts to what he learns.

Consequently, I have included my own opinions and

criticisms of the material presented, wherever I
have felt them to be warranted.

After all, when

circumstances do not permit the possibility of doing

original investigation on a medical problem, the next .
best thing is a critical analysis of the work of

· I have not attempted to cover the entire

literature on the subject.

Such a task would be not

only Herculean, because of the presence of literally
thousands of contributions on the topic, but also

profitless, because of the fact-that the literature
on the shock therapies has its share

Which creep into the literature of any medical. topic.

I have includ� a few specimens of What I consider to

be worthless contributions, in order to demonstrate

how the question under consideration has becom� unne
cessarily contused by reports Which possess neither

. scientific accuracy nor statistical. completeness.
In the preparation of a work as extensive
as a senior thesis, one is bound to carry away with

him many ideas over and above the actual material
which he has learned.

In this regard, I have found
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that the research I have done on rrry topic has impressed
upon my mind, above all else, the eternal truth expressed

by the rather of our profession in the most famous ot
his aphorisms:

difficult".

"Experience is fallacious, and judgment

Chapter I

.Th! History of the Shock Therapies
The heritage Which we call modern medicine

represents the summation of all the significant medi

cal achievements of the past.

It is merely the present

status ot an evolutionary process analogous to the

biological course ot development Which has produced

the current species of organisms; both phenomena re

present a steady march of ever-increasing complexities

stemming from rudimentary and relatively undifferen
tiated beginnings.

Throughout the countless centuries since the

first physicians took on the task of alleviating the

ills of their fellow-man and began to pass on their

knowledge to others, the growth-processes ot medicine
have always been essentially the same.

The princ ipal

difference between the medical progress of today and

that of past generations is not one ot fundamental na
ture but rather one·ot rate of growth.

For, under the

stimuli or rapid advances in the physical and biolo
gical sciences, an ever-increasing host of workers
engaged in medical research, and a constant pooling
- 5

- 6 -

of the 1nt"ormat1on obtained, modern medicine has
advanced., and is continuing to advance, at a rate

equivalent to a geometric progression.

Within the framework of this process,
new therapeutic agent� have been characterized by
great variations in the amount ot research and the

degree of collective·effort necessary for their-d�••
lopme�t.

F.ach method of shock therapy can be consi

dered to be the fruit of individual investigation,
rather than the result ot group research, and each
of them has enjoyed the privilege of widespread

clinical use soon after its discovery.

Although the shock therapies as we know
them today were inaugurated only within the past

decade, still, as with many other discoveries in

medicine, their arrival on the medical scene was not
entirely unprophesied.

For centuries, clinicians have

observed that severe emotional and profourn physical

stimuli are able to bring some mentally 111 patients
back into contact with their environment.

The herb

hellebore was used in the treatment of me ntal dieease
several hundred years ago.

In 1755, Auenbrugger Observed

tour patients who suffered. trom "mania" with "periodic

raving madness" and who were treated with hellebore (1-).
The reactions Which he described were, among others,

✓

a combination o� coma and generalized convulsions, or,
as we would describe it today, a combination of the

reactions to insulin and to metrazol or electroshock.
Paracelsus, early in the sixteenth century,
is credited with the use of camphor by mouth for the

cure of mental disease by the production of convulsions (1).
The drug was also used by Oliver in 1781, who administered

it to relieve a manic patient (2).

Camphor was generally

used throughout Europe tor the same purpose in the second

half of the eighte�nth century, but its use was gradually discontinued and forgotten without any obvious
reason.
More recently, acute psychological changes

had been observed to result from changes in oxygen ten

sion, and experimentation with high concentratiorus of
carbon dioxide had shown that temporary beneficial
results were obtained in catatonic stupors (3a).

With this background, meager though it is,

the medical mind was not entirely unprepared for giving
sympathetic attention to the first reports of the pre
sent-day fathers of the shock therapies.

Ot the three

methods of therapy in most general use during the past
decade -- insulin, ·metrazol, and electroshock -- insulin
takes precedence chronologically.

Prior to the introduction ot hypoglycemic
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shock therapy, insulin had proved its value in exerting
a quieting effect on conditions of agitation and was

used chiefly in cases of delirium tremena am catatonic
excitement; Steck reported such use of the hormone in
moderate doses since 1929 (3b).

Other workers gave

insu11n to patients Who refused to eat.

Appel, Farr,

and Marshall (4) in 1929 were some of the first workers

'

to report the use of inaulin·in combatting the problem
of undernutrition in psychotic patients.

Bennett and

Semrad ( 5), among others who used the drug for the

same purpose., reported that, co-incident with the gain
in weight of their patients, there appeared in many
cases a striking improvement in behavior am mentation,
and a return of normal affective.tone.

Also, practi

cally all of their patients became more accessible for
psychotherapy and other therapeutic measures.

In all such uses of insulin in this period

of prelude to the hypoglycemic shock era, there was

neither the ambition nor the hope of influencing the

psychosis as such.

Moderate doses were administered

and shock symptoms avoided.
The use of insulin as a direct therapeutic
attack on psychoses, known to us today as the hypo
glycemic shock treatment, dates from 192�.

Although

- 9 -

the treatment was discovered in that year, the me thod
and the results in the first treated eases were not

published until 1934, and the therapy did not begin to
receive widespread trial until 1936.

Hypoglycemic shock therapy, like so many other

discoveries in medicine, was come upon. quite by accident.
Interestingly enough, the discovery occurred almost si
multaneously with another great epoch�making accident
in medicine, tor it took place only one_year before

Fleming's chance observation or the inhibition of bac
terial cultures by the Penicillium notatum �old.

Manfred Sakel, who had had a wide experience in the

use of insulin in drug addiction, began in 1928 to
give large enough doses to produce hypoglycemic states.
Unintentionally, severe hypoglycemic shocks occurred.

This event and its results are best expressed in Sakel's

own words (6):

"The therapy is an outgrowth of obsel'V'ations

made by me in the course of the attempted treatment or
morphine addicts.

I thought, first of all, that insulin

abolished. the phenomena of irritation during abstinence
from morphine.because the nerve cells were blocked and
their function quantitatively affected.

Starting from

this observation and this idea I attempted to influence
other states of excitation by means of insulin.

At this
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point, as often happens in such matters, I was helped

by chance.

By chance I produced. deeper hypoglycemic

reactions than I had intended.

I was able then to

observe that such relictions led to much quicker and
more substantial alterations in mental states, and could

even cause psychotic symptoms to vanish.- I endeavored

to evaluate these observations systematically and drew

the practical conclusion that hypoglycemia was evidently
responsible for these changes.

"I was led by the following observlitions

treat psychoses by hypoglycemia.

to

The intense fixation

seen in psychotic anomalies is toned down, the rigid

pent-up personality is relaxed, the affect ls reversed,

and this reversal is maintained."
Thus the origin of hypoglycemic shock therapy,

Which is, as Sakel puts it, "an etiologlcally non-specific
(though clinically specific) treatment for psychoses".

Sakel introduced the therapy 1n Vienna in 1933,

and he began publishing his method and results in 1934.

In 1935 the treatment was initiated at various centers

throughout continental Europe, to be follmred a year
later by England and the United States.

Since 1937,

insulin shock therapy has been granted an extensive

�11n1cal trial throughout the world.

- ·11 -

In contrast to 1nsu11n therapy, Which was

discovered by accident, the use of metrazol as a form
of shock therapy was brought about through a means Which
is as common ln the history of medicine as is the oc cur

rence of chance discoveries; namely,. through a miscon
ception.

Ladislaus von Meduna, the father of metrazol
therapy in psychiatry, had made the observation that
spontaneous convulsions occurring in cat�tonic schizo
phrenic patients were followed by a prompt remission.

Re also noted that an association between epilepsy

and schizophrenia is extremely rare.

From these ob

servations, he made the fo�lowing deduction(?):

"Between schizophrenia and epilepsy there

exists a sort of biological antagonism Which must be
expressed in the pathological course of the two diseases.

Without being able to characterize these pathological

actions, I feel justified in asserting, a priori, that
these courses are either mutually exclusive or they do

at least to a great degree weaken each other in their
mutual efforts."

From this working bypothesis, Meduna reached
the conclusion that an epileptic seizure would alter the
biochemical and hematologic substratum of the organism
in such a way that a further developnent

or the schizo-
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phrenic process would be inhibited and a remission made·

possible.

Of course, the biologic substratum is not the

same in induced as in .i1d1opathic convulsions •. Am, in
the light of present evidence, to be presented in a later
chapter, that metrazol therapy is much more effective

against a:ftective states than it is against schizophrenia,
it would be necessary for Meduna, in order to be consist
ent, to postulate the existence of biological incompa

tibilities between affective psychoses on the one hand,
and epilepsy on the other.

In 1933 Meduna started administering convulsive

therapy on the basis ot the conclusions from his working
hypothesis.

Af ter preliminary animal experiments had

indicated to him that induced convulsions did not cause

major damage to the central nervous system, he began to

use camphor, the same drug given four hundred years

previously by Paracelsus, injected intramuscularly in
a number of schizophrenics.

Because of the definite

disadvantages of camphor, such as the possible occurr

ence of abscesses and pain at the local site, and the

difficulty in predicting the �xaet onset of the seizure,

,

Which may occur at any time from one-half to three hours
fellowing the injection, Meduna soon discontinued the
use of.the drug as a convulsant and substituted for it
pentamethylene-tetrazol (metrazol or card1azol), a syn
thetic product, which has the same pharmacolog1c effect

- 13 -

as camphor and 1n addition to low toxicity, possesses
the advantage of being soluble in water, therefore

becoming suitable tor intravenous injection.

The re

sorption of the drug is rapid and the seizure almost

1mmed.1tt.te, thus further increasing its advantages over

camphor.
Meduna published his first article on the
Since 1935 the method has been

use,of metrazol in 1934.

given a clinical trial as widespread as that enjoyed
by insulin.

For reasons to be discussed later, metra

zol shock therapy has now passed the peak of its uti

lization and is rapidly achieving the status of an

outmoded method of treatment, its role in psychiatry
having been taken over by the youngest of the shock

therapies -- electroshock.

Shortly after the inauguration of the clinical

use of metrazol, its marked disadvantages became appar
ent to those using it.

Because of its untoward phy�ical

complications and mental anguish, wnich in some cases

became so marked as to make the treatment very unpleas
ant for the pat.lent and sometimes prevented continuance
of the treatment (1), it became necessary to find a

method that produced at least the same good results as
metrazol, one that did not give rise to the complications
of metrazol, one that could be carried out even more
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easily than by intravenous injections, and one th at
could be applied_with more uniformity as to the -intensity
am duration of the-treatment.
With these aims in mind, Bini (8) in 1937
conducted convulsive experiments on animals, with
electric currents.

Fis investigations, although they

led directly to the subsequent clin�eal use of electro

sh�k, were far from being revolut+onary, for electrical

experiaents in psychiatry have a history which stretches
back more than fort,- years.

Leduc in 1902 produced

narcoses, states of stupor, and general anesthesia by
the use of electricity (1).

A year later, Zimnerman

and Dimler succeeded in producing epilep tic attacks in
animals by using inter.rupt� galvanic current (1).

After them, numerous other workers confirmed the possi
b ility of obtaining at will narcosis, epileptic attacks,
catatonic states, and general anesthesia, by varying

the intensity and character of the current, the form ot

the electrodes, and their point of application (1).

While many, as indicated above, have utilized

e1ectr1c current for the production of convulsion& and
unconsciousness in animals, it is to-Bini and his co
worker Cerletti that the credit must go for applying
the method clinically.

In 1937, working on dogs, Bini

produced epileptitorm convulsions but also caused severe

- 15 damage to the central nervous system, as determined
at autopsy (8).

R'e carried on, however, until he .

found the current Which produced convulsions in ani

mals without ca using damage to their nervous systems.
In 19�8 Bini collaborated with Cerletti in using this

current on humans, by applying 90 to 125 volts of
alternating current for 1/10 to 3/10 of a second
to the head ot the patient.

They reported only a

few cases, and it was their belief (1) that the

therapeutic efficiency of their new method of therapy
was at least as good as that of metrazol, but without

the disagreeable subjective and objective complications
of the latter.
There has recently been reported (116) the

use of a modified form of electroshock ther apy which

has been given the name of electronarcosis.

By this

method a steady electric current, of a lower milli

amperage than that used in electroshock, is ma;ntained
for approximately seven minutes.

Although it has been

claimed (116) that the results obtained in schizophrenia
are sup6r1or to electroshock and similar to insulin, there
has not as yet been enough confinnat1on of these claims

to warrant conclusions as to the value of the method.
Electroshock therapy, in use in Italy since
1938, was rapidly adopted in England and �olland (1),
and by the end of 1941 the method had been put to use

- 16 in more than 140 hospitals in the United States (41).
It is now g,nerally conceded to be the method of choice
in the administration of convulsive shock therapy.

Cb.apter II

The Shock Therapies in Schizophrenia
Throughout the decade Which has passed since
the initial clinical use of the shock therapies, the
strongest t'ortress against whiQh this barrage or thera
peutic weapons has been directed. has been the disease

which continues to justify its appellation of the mystery
of psychiatry.

In the entire realm of medicine there

is no disease Which rivals schizophrenia in regard to

morbidity.

In this respect it represents a.more serious

problem than either tuberculosis or carcinoma (9).

'!'here are more hospital beds occupied by its victims

than by the suffe rers of any other single disease.
There are actually twice as many hospital cases of

schizophrenia as of tuberculosis (9).

Such being the case, it is obvious that any
therapeutic measure which would make it possible to
directly attack and successfully eradicate this scourge
could be rightfully regarded as one of the greatest
medical vict.ories of our time.

It is not surprising,

therefore, that When the hypoglycemic and convulsive

shock therapies stepped onto the psychiatric scene,
- 17 -
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hopes ran high and enthusiasm was unrestrained.
Fuel was added to the flame of general op
tl.mism by early reports of spectacular achievements by
the originators of the methods.

Sakel, in summarizing

the results in the insulin treatment of his first one

hundred cases of achizophrenia (10), found that where

the duration of the disease did not exceed six months,

70% of•the patients had full remissions and were a ble

to return to their former work, and that an addit ional

1ai

had good improvements.

In all eases of over six

months' duration, the results varied in inverse rela
tion to the length of the illness.

These results

Sakel compared with apontaneous remissions among un

treated. patients, varying from 5� to 20%.

Meduna, likewise, achieved results with

metrazol which were as gratifying as those of Sakel,
if not more so.

The reports on his earliest cases (11)

indicated, as did Sakel•s findings, that the most spec
tacular results were obtained in schizophrenics whose

duration of illness had been not longer t�an six months.
Out of a series of 36 such cases, Meduna obtained re

mission in 33, a figure equivalent to 91%.
In the decade which has passed since the
publication of these inltial glowing reports, the question

- 19 o:t the e:t:ticacy o:t· the shock therapies in schizophrenia ·

has become a hotly-contested battle, with little unan1�

mity of observation or opinion, the reasons for Which we

shall presently consider.

To illustrate the great variance of results

obtained, let us examine a review (12) ot three large

surveys, in New York (1938-39}, Ohio (1940), and On

tario (1941).

The percentage of recoveries o:t schizo

phrenic patients treated with metrazol were 1.6, 15.2,
and 31.o, respectively; the percentages for those

treated with insulin were 12.9, �1.2, and 29.1, re-

'spectlvely.

The following 11st of percentages ot

recoveries, which I have compiled from the reports
or the workers listed below, demonstrates an even
greater discordance in findings�

-

Those investigators

listed
below under. A treated their patients with hypo.

glycemie therapy, those under!! with convulsive therapy,
and those under.£ with a combination of the two methods:
Investigator reporting

A

Ross (13)
Jlalzber (14)
Sav1tt '15)
Bateman and Michael (16)
Cheney and Clow (17)
Bond and Rivers (18)
Gottlieb and Huston (19)
Weil and Moriarty (20)

Year
193'7

1938
1938
1938
1941
1942
1943
1944

Percentage
Patients
treated of recoveries
32.0
286
12.9
1,039
57.0
45
32.0
416
50

188
66

. 20

16.0

33.0
35.0
75.0

- 20 B

C

Ross (40)
Bateman and Michael (16)
Hemphill (21)
Smith et al. (22)
Neymann et al. (23}
Kalinowaky and Worthing (24)
Rennie (25)

1939

579
114
16

Notkin et al. (26)
Taylor (39)

1940
1942
1942
1943
1943
1943

200
'70

34.4
44.4
32.8

1943
1945

100
214

71.5

4.4

523

26.0
3.5

o.o

90

o.o

The great variations in the recovery rates

listed above will give the reader an indication of

the reason why there has been a lack of agreement on
the value of the shock therapies in schizophrenia.

By today the number or published reports dealing with

the shock therapies has reached staggering proportions,

running into the thousands.

In view or this tremendous

amount of investigation, one might expect some concord
ance in the results obtained.

Such expectation is gra

tified 1n the question of the efficacy of the shock

therapies in the affective psychoses, as will be de
monstrated in the next chapter.

Why, then, has there

been a lack of consensus 1n the case or schizophrenia?
The reasons, as I see the problem, are complex

and multiple.

Discordances in results and findings in

any scientific work indicate the necessity of additional

investigation am suggest that there is some lack

or
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,unitonn1ty in the selection of material, in the tech

nical procedure, or in the interpretation of the results.
In addition to finding all these factors operating 1n

the problem at hand, I have observed, in a distress

ingly large number of repoPts, evidenc�s ot a pitiable
lack ot knowledge of, or regard tor, accurate statis
tical methods.

In some instances, e. g. (15, 20, 22),

the number of cases presented is so 8D1B.ll that the

statistical standard error becomes enormous and yet

is not recognized as such by the investigator sub
mitting the report.

Worse yet, some investigators

make little attempt to do much besides presenting

raw data without benefit ot statistical inference.

In one such example (27), the number of cases studied:

is large -- more than one thousand; a study or a group

of this size, 11' done with more care, would un4oubtedly
have resulted in a·significant contribution, rather
than a mere mass of data.

It is thus evident that an evaluation of

the shock therapies must become, to some extent, a�
eY&luation of the shock therapists.

Over and above

this factor, however, there are many aspects of the
problem whicti eonstitute peculiarities inherent in
the specific nature of schizophrenia, peculiarities

Which challenge one's critical judgment of even the
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most painstakingly accurate statistical survey.

In the first place, in attempting to evalu

ate a particular form of therapy in any disease, it

becomes a matter of fundamental importance to study

the course of the disease in untreated cases.

No

competent laboratory worker would ever think of forming
conclusions on an.experiment without the presence of
controls.

In a clinical experiment, such as the intro

duction of a new method of treatment, how can one hope

to arrive at a rational verdict without similar scien
tific safeguards?
It is obvious, therefore, that any attempt

to arrive at a just evaluation of the shock therapies

in schizophrenia without an adequate cognizance of the
natural course of the disease if left untreated, is as
unscientif'ic as it is futile.

Schizophl'enia being the

chronic disease that it is, with remissions and relapses,

and with all degrees of exacerbations and improvements,

it consequently becomes necessary to consider the course
of the-disease from the long-term viewpoint.

Many cases, apparently recovered or much im

proved, are dismissed from the hospital at the time of
such recovery or improvement, only to relapse at a
later date and be re-hospitalized.

Others of this

group maintain their recovered status over a period of

- 23 years.

While those patients who have never shown any

cases.

A true picture of the final outcome of the

�mprovement constitute the group of chronic hospital

disease ca� therefore be constructed only by the use

of extensive follow-up studies over a number of yea2's.
There have been a number of such studies,

emanating mainly from state hospitals.

The duration

of follow-up varies from two years in some up to ten

years in others.

Rupp and Fletcher

(30)

performed

this type or investigation on a total of 641 sch1zo

pbren1os, all of Whom were hospitalized in the pre
shock therapy years between 1929 �nd 1934 and were
followed for a period of five to ten yea��•

The

recovery rate for this gr�up was found to be 16�.

S trecker 160) collected spontaneous-remission

rates from e1·even sources in the literature, with a

total of 581 eases, and found an average figure of 24%.
Boni and Rivers (35) noted a consistent rate of between
10% and 20% for spontaneous remissions over the years
at their hospital.

The figure noted by Bateman and

Michael (16) for 325 patients was 15%.

Guttman and

his co-workers (61) followed up a group of 280 and
noted a spontaneous recovery rate of 33%, the highest
rate among all these reports.

The lowest rate ot all

is to be found in Malzberg's series (14), where, out
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of 1,039 patients, only 3.5% were considered recovered.
On

totalling the above reports, I find that

out or a grand total or 2,833 non-shock-treated patients,
364 spontaneous recoveries occurred.

be 12.8% of the total group.

I compute this to

The pw»blem has recently been attacked, and

quite f'<>ree.fully so, from an entirely different angle,
statistically speaking, by Penrose and Marr (12).

Realizing that the percentage of' recoveries of' shock-

treated patients varies so widely f'rom one report to
another that any attempt to evalu ate the treatments

ls inadequat�, they decided to attempt such appraisal
by estimating the prospects of spontaneous recovery in
the group of patients concerned.

The method which they

devised for this procedure has as its essence the com

parison of the actual number of shock-treated c�ses

remaining on the hospital books at a·g1ven time, with

the expected number, calculated f'rom a rar:dom sample
of the mental hospital population.

They constructed

tables to show the chance of a patient's still being

on the hospital books at a given point of -time in the

f�ture, When the age on first admission, sex, and
length of time since admission are all taken i�to
account.

The tables were calculated from a random

sample, composed of 8,016 case histories or mental
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hospital patients.
Th.is method of determining controls by means

of caleulating expected figures was tested by Penrose
and Marr.

They took, at one hospital, all the patients

who had been recomme:rrled for shock therapy but who, for
one reason or another, did not rece1Ye it.

Here, the

observed and expected numbers of patients agreed very
closely in this untreated group.

We can assume from

this experiment, therefore, that the total expecta

tions, as calculated by Penrose and Marr, tend to be
fairly accurate.
On the Whole, the figures of Penrose and Marr
suggest that shock therapy has definite value i'n keeping
a-certain proportion of treated patients out of the hos
pital for periods of time extending over one or more

years, the proportion amounting to sanething between
6� to 11% of treated cas�s.

The efficiency-record of

the shock therapies was found, in this study, to be

lowest for schizophrenics.

According to these inves

tigators, out of over 1,000 cases of schizophrenia
only 34 could be supposed to have been discharged
in response to treatment.
Invaluable though such studies are in helping
one to arriv•·at an adequate standard of comparison be-
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tween treated and untreated cases of schizophrenia in
large groups of patients, still this method of analysi s
falls short of answering adequately the question Which
cannot fail to�be_uppermost in the mind of the psychi
atrist as he considers each new ease of schizoph�enia;
namely, what results can he expect from the use of
shock therapy in the particular patient at hand?
In this connection, I have found that the
more one studies of medicine, the more one realizes
how specious are the rigid categories and the conve
nient pigeon-holes Which pervade the entire field.
Systems of detailed classification tend to confer on
medicine the apparent status-of an exact science,
while in �etuality Nature recognizes no such man-made
designations but presents before us an infinite
variety of aubtlJ differing.forms.

This 1s as true

of psychiatry as it is of any other branch of medicine,
and it 1s particularly evident in the disease known

to

us as &ehizophrenia.
I say "disease", since sell.1.IJophrenia is
usually alluded to in the singular; however, when more
closely studied it becomes apparent that we should with
greater accuracy refer to "the schizophrenias", since
the term "schizophrenia" is really more a description
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or various reaction types than a single disease ent ity.
In addition to the four typical varieties of the dis
ease -- catatonic, paranoid, simple, and hebephrenic -
the diagnosis of schizophr�nia is very.rrequently con
ferred collectively on a number of quite atypical
clinical pictures.
Langfeldt (29) speaks of typical cases as
those in whom the illness is clearly of endogenous
origin and Who pres ent no atypical or unusual symp
toms, and he considers the atypical patients as those
whose illness resembles a manic-depressive psychosis
or was precipitated or influenced by exogenous factors,
and those where the diagnosis of schizophrenia is
doubtful.

According to Lewis (28), these atypical or

pseudoschizophrenic forms compose the majority of
schizophrenic patients treated in some hospitals.
Lewis concludes, am rightfully so, that herein lies
one of the major causes of the differences in the
reported clinical results, Which are certainly more
favorable in the p seudoschizophren1c forms than in the
genuine nuclear types, since the atypical forms cannot
serve to test the value or any method of treatment to
be interpreted in terms of the whole category ot schi
zophrenia.

Obviously, the inclusion of large numbers

of atypicals in statistical data on therapy in schizo
phrenia tends to produce "loaded" resultant figures.

- 28 In addition to the presence or a large number

of atypical forms, there are innumerable other variables
all of Which have distinct bearing on the course of the
disease and the final outcome for any given patient.
We must take into account such factors as precip1-

tating causes, age, sex, race, physical constitution,

duration of illness, social and economic status, fa

mily constellation ,. heredity, and psychological fac
tors.

As Lewis (28) analyzes this phase of the prob

lem, studies of the individual over a number of years,
which include the pre-psychotic character, the intel
lectual status, the social and physical disease fac
tors, t�e bodily form, and the onset and course of

the psychosis, are necessary in order to obtain per

tinent lntonnation on what varteties of reaction ten:l

generally toward recovery, remission, and improvement,
and those which tend in the direction of a poor prog
nosis regardless of the type of treatment applied.

Realizing the importance of adequate criteria

with which to assess the prognosis of any given case
of ech1zophren1a, Chase and Silverman (31) conducted
a survey of the literature on the subject.

They found

that the prognosis is most r�vorable when the duration
of illness is short, the type of onset acute, exogenic
precipitating factors obvious, an element of confusion
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present, and atypical symptoms (especially manic-de
pressive symptoms) prominent.

Concerning the relation

ship of constitutional type to prognosis, they noted

that the pyknic build eonf'erred a more favorable out

come than the asthenic.

Also, extroversion and an

adequate pre-psychotic life adjustment tended more
favorably than introversion and inadequacy of reaction

to life.

In regard to the relationship of schizophrenic

type to prognosis, these investigators found that, as

might be expected, the acute atypical eases, unclassi
fiable, have an especially favorable prognosis, and

that of the four nuclear types, the catatonic offers
the best proapects, the next best being the simple and

hebephrenic, with the paranoid being apparently the

least favorable type.

sex, education, abilities, aDi

psycho-sexual history were found to have no prognostic
a1gn1f1.cance.

Age of onset was likewise noted as an

insignificant factor, except that a relatively late
age tends to offer an unfavorable prognosis.
Correlating their results of insulin and
metrazol therapy with the prognosis as determined by
these prognostic criteria, Chase and Silverman reached

th� eoncluslon that whon tho

pro�nQSl9 1s ravor�b1o�

shock therapy is beneficial, but when it is poor, the

- 30 -

treatment is of little value.

'1'.hey found that shock

therapy shortens the duration of illness in patients
with a good prognosis, and, even more significant, that·

it may be the deciding factor in patients with a doubt

ful prognosis.

Katzenelbogen's findings (38) are quite in

agreement with these conclusions.

Writing on the ef

ficacy of insulin therapy, he noted that the treatment

gives the best results_ in two types of schizophrenic
reactions -- schizophrenia in psychoneurotic indivi

duals in Whom psychogenic factors appear to be the
immediate provocative agents of the psychosis; and

schizophrenia with a large question mark, Where the
diagnosis is the subject of controversial opinions
am remains uncertain to all concerned.

Katzenel

b�gen concluded, as had Chase and Silvennan, that

the therapy only accelerates the favorable outcome

in-those schizophrenics in whom the ordinary hospital
care would accomplish simil�r results.

Cheney and Clow (17), in conducting a similar

type of' investigation, reached substantially the same
conclusions.

In addition to making observations simi

lar to those listed above, they noted that patients
who were to improve usually showed evidence of' such
improvement relatively early in the course of treat-
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if

the results did not appear early,

a prolong-eel course of treatment rarely produced re
covery.

In this connection, there i s one prognost ic

point on Which a general agreement has long since been
reached.

Th. is is th.e factor of duration of illness.

Almost without exception, every worker who baa investi
gated the problem has found th.at bes t therapeutic

results are obtained in cases •1th a short durat ion
of illness .

Ever

since the original reports by Meduna

(7) and Sakel (6), practically all workers have noted

an inverse proportion between effectiveness o:f therapy
and length of p sychosis.
I.f'

such

therapies have no

be the case, that is, 1:f the
spec ific

curative effect

in

s hock

sch izo

phrenia but merely accelerate or facilitate improve
ment in,those Who have the cons titutional or innate

capacity for improvement, then a highly significant
factor

in

the production of wide discrepancies among

various reported recovery-rates become s at once ap
parent.

For how can one reas onably expect to find

the same re sult s in a serie s of hand-picked pat ients
with good p�e-treatment prognosis as in a group re
pres enting a random sampling of the schizophrenic
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population?

With this factor in mind, among others

to be analyzed presently, we begin to make some sense
out o£ an apparently hopelessly conf'used state of
affairs in Which the range of published percentages

or cures runs anywhere from seventy-five down to zero.

In this regard, it is important to note that

the division of _cases into various grades of improve
ment ranks high in the list of the myriad stumbling

blocks which beset the path of anyone who attempts to
evaluate the results of shock therapy in schizophrenia.

The placing of a patient within the cat�gory of "re

covered", •much improved", "improved", or "unimproved"
is at best only a subjective evaluation am therefore

liable to large personal errors, unless objective

criteria for such designations are accepted and used

by all investigators.

In an attempt to bring order

out of a chaotic state or affairs in which a C°'1par1son
between the results of one investigator and those of

another is difficult if not impossible, Ross and his

co-workers (34) in 1941 suggested a set of objective
criteria to be used by all investigators submitting

reports on results of shock therapy.
According to these suggested criteria, cases
are designated as follows (34):

"To be classified as

'recovered' the patient must have become entirely
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symptom-tree and must have developed insight regarding
his illness.

.

By 'insight' is meant that the patient

must 1'ul.ly realize that he has suffered a mental ill
ness and that his symptoms were in fact a part of this
illness.

Re mu.st also be able and willing to speak ot

his illness in detail and objectively, and with normal

affect, and he must be able to adjust well in the
community at his pre-psychotic level.

"The term •much improved' means that the

patient is entirely symptom-free but that insight

as defined above is lacking or incomplete, although
he is able-to adjust well in the community at or near
his pre-psychotic level.

"The patient is considered 'improved' if

his symptoms are incompletely alleviated. but less

distressing, so that he is able to make a definitely
better adjustment than before treatment.

"'Unimproved.' is applied to those patients

Who derive no benefit from the treatment."

Shortly following the publication of these

criteria in 1941, one report (3c) remarked that'Ross's
system of classification had already been put into
general- practice.

One is led, however, to question

on what basis this statement was made, since another

writer, in a general review of the shock.therapies (28),

- 34 came out two years later with a plea for general
acceptance of a standard set of class1t1cat1onal
criteria in order to end the anarchic conditions
which still continued to exist.

It is difficult

to determine, fr?m the results reported by various

investigators, exaetly to what extent a common set

of criteria has been used, since in p:ractical.ly no
cases, with rare exceptions, e. g. (14, 19, 34), is

there any statement made by the investigator as to
his standards for the various grades of improvement.
In addition to condemning the lack of us

age of a common set of therapeutic criteria, Ross and
his co-workers (34) have generalized their charge by

stating that "since the introduction of insulin shock
therapy ihere has been little uniformity in anything
connected with itn , a charge with Which, I am sure,

the reader by this point will find little cause for

disagreement.

Ross ard his group further condemn the

fact that "different terms are used to describe the

same condition, and different meanings are given to
the same term.

"Moreover," they state, "the technique

has about as many variations as there are c linics us
ing it."
Here ag�in, then, we find new additions to

the innumerable variable$ which, as I have previously

- 35 emphasized, seriously impede the possibility of reaching
a fair and just verdict in an appraisal of the shock
therapies in schizophrenia.

Th.at the technique of

administration or the shock therapies is a potent fac
tor in determining their efficacy is demonstrated with
crystal clarity in the results obtained by Bond and
Rivers (35) with the use or t wo different techniques.
During the years 1936-1938 these workers used a •mild"

type of insulin therapy.

The principle at that time

was to keep the insulin dose as low as possible and
still �et hypoglycemic stupor.

When the stupor dose

was reached, a reduction was made on the subsequent

ConYUlsions

days if stupor level could be maintained.

were considered. to be a sign of overdosage.

th�y completely changed their technique.

was the· stupor dose considered optimum.

In 1939

No longer·

Rather, they

produced deeper and longer stupo-r by increasing the

dosage, am they no longer considered convulsions as
a contraindication to increasing the amount of insulin.
There were approximately the same number of
patients treated by each of the t wo techniques.

Of

those treated by the old method, 44% .were recovered

or much improved at the end of treatment, as contrasted
with a rate of 63% for those treated with the later

method.

At the end of the first year following termi-
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nation or therapy, the figures were 34% and 6?%,
respectively.

Comparative studies such as this thus give

ciear indication of the fact that the mode of admini
stration of the therapy does make a difference in the
effects on the patient.

As in the question of criteria

for :measuring degrees of improvement, there is no thing
in most reports on therapeutic results to indicate the
method or administration by which those results were
obtained.

One has no means of even surmising, then,

as to the extent

or the role played by differences of

technique in the production or discrepancies among

various reported therapeutic results.

Regarding the effect or the duration of

therapy on the prognosis of the treated disease,

Malzberg (14) found that the rate or recovery and
illlprovement decreased as the duration

increased.

or treatment

In other words, patients who respond fa

vorably to insulin therapy tend to do so early 1n
the course of treatment.

Similarly, Gralnick (31)

is so convinced of diminishing returns in an ·extended
course of treatment that he sees no reason for continuing
the therapy in patients_who do not show definite im
provement by the time they have had 25 to 30 treatments.
In his experience, such patients do not become suffi-
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treatments t�ey receive, and any improvement that does
occur is fleeting in nature, according to him.
Katzenelbogen (38), however, could find no
consistent rel�tionship between the therapeutic re
sults, on the one hand, and the number of treatments,
on the other.

Re concluded therefore that "aside from

the pharmacodynamic effect of insulin there must be
other int'luences at work".

Re is of the opinion that

inau1in makes the patient more .rec�ptive to other
types of therapy by establishing a better pat1ent
phys1cian rapport.
Th.is view has been expressed by enough other
workers to make one seriously question the specificity

of the ehock therapies in schizophrenia.

Graln1ck (37)

is convinced tnat it is not merely the insulin-hypogly
cemia that counts, but the specific insulin-treatment
situation Which does.

He considers that the fact that

principally eases of short duration do so well is
understand.able only from this point of view.

According

to his view, these p�tie nts are elose·enough to reality
to respond to the treatment-situation, whereas the other s
are so withdrawn and psychologically fixed that the drug
can hav� little or no effect.
ever, whether this stand

is

One is led t o doubt, how

entirely justified, in view

of Ross•s observation (40) that beneficial results from
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the insulin treatment of all cases of schizophrenia,
regardless of duration of the psychosis, are greater

than the results in untreated groups.

Ross tound that

although the recovery am improvement rates are in
versely prop�rt1onal to the duration or illness, still

there are enough good results obtained in cases Where
the duration is over two years that it would be an
error

to neglect such cases.

It is evident, nonetheless, that the shock

therapies are more effective if used as an adjunct to
other psychiatric techniques than if relied upon as
the sole therapeutic weapon.

The importanee ot the

use or the well-establis�ed conservative psychiatric

techniques, particularly psychotherapy, is stressed
by many different investigators.

The general accept

ance of this viewpoint is apparent in the findings ot

an excellent survey on the use of the shock therapies,

prepared in 1942 by Kolb and Vogel (41).

These in

vestigators conducted a poll of 305 mental hospitals

in the United States and reported that the majority
of the hospitals polled placed great emphasis on the
importance of the combination of shock therapy with
psychotherapy.

• Th.is consensus is echoed in the words or

one observer (42) who states that "shock therapy is
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a means of temporarily improving the patient's mental
state so that he is accessible, and by means or psycho

therapy can be carried on to a wholesome mental state."
The survey of Kolb and Vogel indicates
that many hos..

pitals are usi� the shock therapies as an adjunct

not only to psychotherapeutic interviews with patients
but also to the total psychotl'terapeutic approach, in-

eluding programs of physical education,, occupational

therapy, hydrotherapy, physiotherapy, and the sociali
zation program which is practiced in the better-managed
psychiatric units-.

One is thus.led to the view that the shock

therapies cannot be considered specific curative

treatment in schizophrenia, that they are best used

in conjunction with, and not to the exclusion of, other
methods, and, as discussed previously in this chapter,
that they merely accelerate or facilitate improvement

in those who have the constitutional or innate capacity
for improvement.
Granting all this, can one then conclude
that shock treatment of schizophrenia has little more
to offer than the use of more conservative measures?
There have been certain observations which tend to
indicate that this is far from being the case.
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In the first place, regardless of the question

of permanency of cure, any method of treatment Which

can bring about a significant reduction in the hospital

population of schizophrenics is.to be regarded as a
therapeutic tool ot no mean usefulness.

Th.at thie

has been accomplished ia conclusively shown in a re

cent survey of 2,004 insulin-treated schizophrenics,

conducted by Folks (43).

According to this investi

gator's analysis, the average hospital stay of a schizo

phrenic patient with a duration of illness iess than

18 months, is approximately 7 months without insulin
shock therapy, whereas with the therapy this is reduced
to approximately 3 months.

In addition to this quantitative decrease

in the length of hospital stay, there appear to be

qualitative differences between shock-treated and non
shock-treated patients Which tend to modify any mood

of pessimism generated by such·reports as that of
Gottlieb and Fuston (19), who found no difference in

recovery-rate between their insulin-treated and their
control patients.

Bond and Rivers, for example, in

a long-term survey (36) published. in 1944, noted that
the quality of the remissions in their insulin-treated
cases was of a much higher standard than in their con
trol cases.

Of course subjectivity necessarily plays.

- 41 a large role 1n the assessment of qualitative differ
ences in any medical question; however, Bond am Rivers
formed their impressions not only from personal inter

Yiews with their patients but also from information
contained in follow-up letters from the patients•

physicians and relatives.

Th.at this difference in

the quality of remissions is present from the onset
of remission is evidenced by such reports as that of
Strecker (44), Who noted the phenomenon as early as

1938.

Thus far we have considered mainly the ef
fectiveness of insulin shock therapy in producing
recovery and improvement in aehizophrenia.

A question

of even greater significance is, how well-sustained

are the favorable results brought about by the therapy?
In other words, what is its long-tenn. value?

I have found that one of the most signif'icant

factors operating in the production of discordant esti

mates of the end results of shock therapy is the highly

variable time allowed to elapse between the er.d of the
therapy and the final examination of the patient.
Unfortunately, relapses are not uncommon among shock
treated schizophrenics, and therefore short-term esti
mates of final quantitative results

become misleading.
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Horwitz, Blalock, and Farris (32), for ex

ample, found that 25% of their improved patients re
lapsed within several months to a year after the com

pletion of insulin treatment, am at the time of their

report (1938) they felt justified in assuming that still
more relapses would subsequently be added to this al
ready quite large percentage.

Such facts tend to .lead one to discount ana

lyses such as that of Malzberg (14), in Which, reporting
in 1938 on the outcome of insulin treatment of 1,039

patients, he gives a figure of 65.3� as the total of

all insulin-treated cases classified as recovered, much
1.aproved, or improved, as contrasted with a figure of

23.4� 1n a similarly large group of controls.

The

difference, at first glance, is overWhelming; however,

after one notes that the period of observation for the

insulin patients was approximately one month While that

of the controls was between one and two years, the dif
ference obtained loses its significance.

I should add, however, in defense of Malzberg,
tnat he admitted the impossibility o f giving a final
verdict on his insulin cases until after following
them for perhaps five years after the close of treat
ment.

Indeed, reporting on the same. group of cases

one year later, Ross and Malzberg (33) noted that 20%
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of the original paroled group of insulin-treated patient�
had already relapsed.

Nevertheless, taking Malzberg's original data
at race-value (and I should state that on analyzing hia
procedures I firn him to be an extremely able and com

petent statistician), one can feel justified in assign

ing a high degree of immediate effecti veness to the
treatment.
In view of the deceptiveness of results ob
tained, as reported immediately at the end of treat
ment, the need for ad4quate follow-up studies becomes
at once apparent.

I have mentioned above that an

analy.sis· of :M.alzberg's original cases one year after

the completion ot treatment showed a relapse rate of

20% within that year, thereby reducing to _45% the ori
ginal figure of 65% for eases considered recovered,
much improved, or improved.

After these eases had

been followed for two more years, thus making three

years since the close of therapy, Ross, Malzberg, and
their co-workers (34) found that this figure of 45%,
for those showing some degree of improvement, remained
unchanged.

The conclusion was made, therefore, that

the condition of the patients had become stabilized
with respect to the possibility of any further deter!-

- 44 oration, and that about 45% showed some degree of

lasting improvement.

Ot this number, 12.9% were con

sidered full recoveries.

A similar much-needed follow-up study has
been conducted by Bond and Rivers.

These investi

gators noted (35) that in all such at-ud ies conducted

at their hospital during the years before shock therapy,

the recovery and much improved rate seemed to run con

sistently between 10% and 20% at the end of five years
after admission.

In the same report, Bond and Rivers

noted an immediate recovery-much improved rate of 54%
(3

to 5 times that of the controls) in a group of 251

cases treated with insulin, but they found that this'

figure had dropped, at the end of one year, to 43%.

At that time, in 1941, they felt that if similar de
creases were to occur in further �ollow-up periods,

the rate at the end of five years might not be far different from the control cases.

�owever, in a later

report (18) they noted that the recovery rate terded

to level off at about 33% in the second, third, aid
fourth years.

The latest study of these investigators

(36)

included a five-year follow-up on 49 cases; of these,
22, or 41%, had maintained their status.

Bond and

Rivers contrasted this figure with an approximate rate

- 46 of 15% on five-year cures among their controls.

I find, however, quite a large fly in this ointment,

�or �tsis misleading to consider that any percentage
of a gr�up of 49 accurately indicates the status of
an equal percentage or a group ot 138 (the original

number of patients ponstituting ·the immediate recovery
rate of 54%).
with a rate of

To contrast a rate of 41% (22 out of 49)

1si

on hundreds of controls is as un

warranted. as would be the conclusion that since only
22 out of the original total of 251 eases showed a

five-year cure, the percentage of such cure is only

22 out-of 251, or 9%.

This illustrates, of course,

the great difficulty involved in conducting long-term

follo w-up studies and in interpreting the results

obtained; namely, that the number of former patients

available for inclueion within data becomes progress
ively smaller with the passing of each year, �hereby

causing a progressively increasing standard error and,

consequently, a steadily decreasing statistical relia
b111ty.
Graln1ck, in a recent seven-year survey (31),
found that although 268 (50%) of a total of 554 insulin
treated patients were_ paroled, 31? (60%) were in the
hospital at the time of the survey six years after the
treatment.

One can assume from these figures that the
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other 40% r�presents sustained results.
Gottlieb and miston (19), in a follow-up
period of four years on 66 insulin-treated cases,
found a tour-year recovery rate of 35%.

Similarly,

Rennie (25), in a one to three year follow-up study

on ?O schiaophrenics, noted that the final percentage

of favorable responses after this length of time (start
ing with a 55% immediate recovery rate) was 32.8.

Also,

Bateman and M1ehae� in a two to three year follow-up

analysis (16) of 416 insulin-treated patients, recorded
a final recovery rate of 31.2%.

The most comprehemive, detailed, -and care
fully prepared of all the follow-up studies on insulin

shock therapy ll'h.ich I have been abl e to fi:rn, is an

analysis published in 1944 by the New York Tempo�ary
Commission on State �ospital Pro�lems (120).

Th.is is

a one to five year follow-up report on 1,128 schizo
phrenics treated at the Brooklyn State �ospital.

These patients were contrasted with 8?6 controls

whO did not receive any form� of' shock therapy but who

were otherwise com.parable, as to sign1f1oant factors,
to the insulin-treated group.
In gratifying agreement with the points
stressed earlier in this chapter, the Commission found
that not only did the insulin-treated patients have a

consistently larger propor�ion able to leave the hospital
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in each diagnostic group than the non-treated patients,
but also that the hospitaliztttion period prior to re
lease was 3.8 months shorter per patient than among the

non-treated.

In addition, the insulin-treated group

had a consistently larger proportion o�_patients Who
were at home the entire period from date of release

to date of study, than the non-treated.

The Commission found, as had Ross, Malzberg,

and their co-workers (34), that the majority of all
patients Who returned for further hospitalization,

did so within a year after release, the number de
creasing with the passage of time.

At the end of

the period of s tudy,_ 58.9% of all the insulin-treated
patients were at home, a,s against 44.0% of the non

treated group.

In contrast to Rosa's system (34) for grading

patients into the four categories of recovered, much

improved, improved, and unimproved, the Commission

judged their results by dividing their patients into

seven "levels of use1'u.1.ness".

It was noted that there

was a consistently larger proportion of insulin-treated

patien ts in the higher levels of usefulness and non

treated �•tients in the lower levels.

According to the designation of the Commission,

"Level 1" is described as "those patients who developed
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beyond their pre-psychot1e level and who at the time

of study were getting along well and better than be'fore

their illness in their social and familial relation
ships.

"Level 2" indicates "those p�tients who were

doing well and at least as well as they did before

their illness".

These two categories together, then,

claee1f1cation�

On combining the numbers of insulin

correspond to "recoveries" in Roas•s (34) system·or
treated patients in these two levels, as listed by

the Commission, I find that they represent 363 eases,
or 32.2� of the total group treated.

The following table represents a sunmary 01"

the 10;.ng-tenn recoveries 1"ollowing insulin shock therapy,
as noted in the follow-up studi�s Which I have discussed

above:

Report
Gottlieb and Huston (19)
Rennie (25)
Bateman and Mi chael (16)
Bond and Rivers (18)
Graln1ck ( 37 ) ·
Ross et al. (34)
New York Commission (120)
Totals:

Number of

patients

treated

66
'70

416
251
554

1,039

11 12a
3,524

R e c o v e r i e s
(Percent} (Number)
35.oi
32.BJ
31.2

33.()%
40.()%

12.�
32-2%

_25.1
22.9

129.8
83.'7

221.6

134.0

363.0
978.1

- 49 -

The total obtained, 978.l long-term recoveries
out of 3,524 insulin-treated patients, correspond.a to

�7.7 %.

It will be recalled. that earlier in this chapter

a figure of 12.8% was computed for the rate of long-te:nn

spontaneous recoveries (364 out of 2,833 non-shock-treated
patients).

Even adding to these figures the rela tively

more favorable number of spontaneous recoveries in the
New York Commission report (193 out of 824 controls),

the rate is increased to only 15.2 % (557 out of 3,657).
In sunnnary, then, the long-term recovery rate

in a grcup of 3,524 insulin-treated patients ls 27.7% ,

While this rate in a group of 3,657 controls ls 15.2%.
Is this dii'ference significant, or 1s it one Which can

be ascribed to randomness?

The answer bO this question

can be determined only by computing the standard error
of the dU-ference.

The standar d error of two proportiona

is equal to the square root of the sum of the squares

of the standard errors of the two proportions.

The

standard error for the proportion of recoveries in the
insulin-treated group is the square root of P (l-P),
If

niere P equals the quotient of the total recoYeriea
(both treated and controls) divided by the total number

of patients subjected to analysis (both treated and con
trol�, and Where N equals the number ot insulin-treated

50 978.1 + 55�
1635.1
3524 + 365, = 7181.0 : 0.214:.
One minus Pis then o.786, and the standard error t or

cases.

P then equals

the treated group becomes equal to the square root ot

(0.214 X 0.786 divided by 3,524); this is equal to the

square root ot 0.000048.

Similar computations tor the

standard error of the untreated group yields, by dividing

the product ot 0.214 and. 0.786 by �,657, a figure equal
to the square root of 0.000045.

'l'he standard error ot

the difference between two proportions, being equal to

the square root ot the sum of the squares of the stan
dard errors of the two proportions, becomes the square
roof of f0.000048 + 0.000045).
out 0.0096, or 0.96%.

This square root comes

The observed difference between the insulin

treated group and the controls wa� 27.7% minus 15.2%,
or 12.5%.

In terms of a standard error of 0.96%, this

difference of 12.5% represents 13.0 standard errors
(12.5% divided by 0.96%).

The upper limit of randomness

of statis�1cal data being general}Y considered to be

2.3 standard errors, it becomes immediately obvious
that the difference observed between the two groups

is highly significant.

The chances of a difference

equivalent to 13.0 s'tandard errors being due to ran
domness are only one in ten to the thirtieth power.
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On the basis of my calculations, I feef
thoroughly justified in concluding that, observed
from the long-term viewpoint, the probability is ex
tremely high that the results of the insulin treat
ment of schizophrenia are quantitatively almost twice
as good as those in non-shock-treated oases.
Of course! realize that the figures I hav�
used represent only a fraction of the total number of
schiZGphrenios who have been treated with insulin (the
survey of Kolb and Vogel (41) showed that 23,651 pa
tients had received the treatment up to the
1941).

em of

However, in statistical analyses one must ne

ceasarily derive clues from samples, since the total
supply is practically never available for considera
tion.

And in the data which I have presented, the

number of patients considered is certainly large
enough to nullify sampling errors.

I feel that the

method I have used is certainly more reliable for
the formation of quantitative conolusions than is
the custom, in some reports I have read, of dis
crediting insulin shock therapy merely on the basis
of finding isolated instances 1n which the final
percentages of cures, in a handful of treated cases,
are equal to the recovery rates observed in an equally
small number of controls.
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•

On the basis of the evidence Which! have

presented in this ohapter, the case for and against
insulin shock therapy in schizophrenia can be sum
marized as follows:
Although the treatment has not lived up to
the high expectations generated by the over-enthusiastic initial reports of its value, still it has

proved itself a therapeutic weapon capable of _producing nearly twice as many sustained recov•r1ea as

occur in non-shock-treated cases.

The benefits to

be derived vary from one patient to another and can
be-expected to accrue, in any given case, in direct

proportion to the prognosis of that case if left un
treated, and to the duration of the psychosis previous

to the commencement of therapy.

Insulin-shock therapy

is valuable in faci litating and accelerating recovery,

thereby shortening the period of hospitalization.

The

treatment, When effective, _is only one step in the pro
cess of rehabilitating the schizophrenic; the best final
results are produced When insulin is used- in con3unction

with other forms of treatment, particularly psychotherapy.

·-

- 53 Faving analyzed the record of the hypogly

cemic treatment, let us now proceed to a consideration
of the role of convulsive shock t�erapy in schizophrenia.
At the outset, it should be stated that
though the term "convulsive shock therapy" applies
both metrazol and electroshock, the former is fast
becoming a matter of historical inte�est only, its
place in the f ield having now been taken over, in the
gr�at majority of hospitals, b7 the latter.

(Inci

dentally, it is 1ntere8t1ng to note the similarity ot
the trend away from chemical and toward physical methods

both in shock therapy and in fever therapy, the latter
being now accomplished by the electr1�ally-controlled·

fever cabinet rather than, as formerly, by the injection

of foreign proteins.)

There is good reason for the rapid �eplace

ment ot metrazol by electroshock, in view of the marked
advantages ot the latter over the former.

have been summarized (53, 55) as follows:

The advantages
Electroshock

produces an unconsciousness and amnesia for the treat

ment, thereby lessening fear of treatment and assuri�
the patient a greater degree of mental and physical
comfort; there is a much lessened degree of psych.omo.tor

agitation rollowing the treatment, patients being usually

- 54 quiet and drowsy at that time; the difficulty with

, inaccessible and thrombosed veins that occurs w1 th

metrazol does not exist with electroshock; and, f'inally,
a larger number

of treatments can be given with a mini

mum of' time and personnel.

Of' course, the main criterion with which to

decide to auppiant one method of treatment by another
is not the administrative advantages of the new method
but its therapeutic efficiency.

For any new therapeutic

technique must be at least as successf'ul as the one Whose
use it displaces before it can be considered as a sub

stitute.

Fortunately, this has been found to be the

case with electroshock.

In 1939, shortly after the

method had f'irst been put to clinical use, Ka linowskJ (45),
although admitting that the number of' cases treated at

that time was too small to allow definite conclusions to
be drawn, reported that the number of' recovered and im

proved cases of ach1zophren1a, treated bJ electrosh�ck,

· corresponded at least to the number of similar cases
Whom he had treated with metrazol.

In an attempt to determine Whether there are
any long-term differences between the results obtained
by the two methods, Pacella and Barrera recently con

ducted a follow-up stud7 (46) on two groups of' patiente,
one group treated with metrazol, the other with elec�ro-
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They found that the therapeutic effects of

both methods are essentially the same.

These find

ings were confirmed in a similar and simultaneous
study by Reznikoff (47).
Shortly after the demonstration ot the dis
tinct advantages of electroshock over metrazol, the
former became recognized as the treatment of choice
in conv ulsive shock therapy and has therefore enjoyed
a rapid general acceptance, as is evidenced in the
large hospital-poll conducted by Kolb and Vogel (41}.
Although metrazol is almost a dead issue
today, the similar! ty of its results to those of
electroshock justify its consideration in an appraisal
of convulsive shock therapy, since for approximately
five years it was the only generally used method of
administration of this type of treatment.
In attempting to evaluate the role of con
vulsive shock therapy in schizophrenia, one finds,
as might well be expected, the same host of variables
which contribute to the difficulty and complexity of
the task of formulating a just assessment of hypo
glycemic therapy.

Also, as in the case of the latter

method, it is clearly evident that c·onvul sive shock
therapy cannot be regarded as a substitute for con-
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servative methods of treatment but must be thought
of as a useful synergistic adjunct to such methods.

Thia fact has long been recognized by the

better quality of investigators.

Meduna himself,

even in·the early days of enthusiastic reception of
bis metrazol treatment, called attention to the fal
lacy of relying solely on any pharmacologic method.

"I should like to mention", he warned (?),
"that this treatment of schizophrenia cannot effect
a complete cure.

For schizophrenia presents a psychic

disorder based on a patho-physiologieal foundation,
and, therefore, we must not only influeme the bio
logical patterns but must also seek to help the pa
ti�nt along psychological lines.

It seems to me

superfluous to emphasize that the treatment of schizo
phrenia can never be suc cessful with mere medical

treatment like an internal ailment, much as I am con
vinced of the purely material nature of this disease.

"The significance of the psychiatric �eat

ment seems to me to be so far beyond doubt that I

consider it unnecessary to look for justU-ication.
The fact is that those Who have teated my treatment
have not achieved my 50-60� success, but. have had
only 36•60%.

The same authors, however, in testing

Sakel's method, had an even lower percentage of re-
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missions; indeed, with both methods there was the
same di.fterence ot 20-30% between them and the ori
ginal authors.

This difference I ascribe to their

neglect of the psychiatric treatment."

Whether Meduna was correct in assuming thia
faetor-to be the only one operating in the production

of the discrepancies between his result s and those of
subsequent workers, it is difficult to surmise, in

view of the many other v�riables Which must be taken

into ae-count When com.paring one case of schizophrenia
with another, as I have previoual7 emphasized.

The

fact remains, however, that Meduna did produce a

spectacularly high degree of success in his early

cases.

In a series (11) of 36 patients with duration

of illness not longer than six months, he obtained
remissions in 33 -- over 91%.

His remission rate in

eases with du.ration of illness up to one and a halt
years was 84%.
high -- 7�.

Up to two years it was still quite

It was conside rably lower but still re

mained. on a relativel7 high level in cases in which

the length of illness was between two and five years
36%.

In contrast to this shining record, one can

cite examples which show the opposite side of the pic
ture.

Ross (40), ror instance, in cont rasting his

- 58 results with metrazol on 523 patients with results on
1,039 untreated controls, found an equal recovery-much
improved rate in both groups -- 14%.

It is obvious

then that D'l.l::ltching one report against another will get
us noWbere in our search for an evaluation of convulsive
shock therapy in schizophrenia.

Because of the great

variety of assignable causes for d�scordance in re·sults,

Which I have analyzed above, the ideal method of at

tacking the problem would be to compare individual
cases with each other.

The closest that most investi

gators come in this regard is to break down their data

into groups corresponding to duration of illness.
Fere, at least, we can note a gratifying degree ot

uniformity; for, almost wi�hout exception, there is

general agreement that, as in the case of hypoglycemic
therapy, the results obtainable by convulsive treat-

ment are inversely proportional to the duration of
illness at the beginning of treatment.

The consensus on thia point is evidenced in

a statistical compilation of results from metrazol in

3,000 cases, prepared in 1939 by Meduna and Friedman (48).
��y calculated a mean remission-rate of 52% for patients

whose illness h�d lasted less than one and one-half years,
with great improvement noted in an ad ditional 20�.

In

cases lasting longer than this length or time, the mean
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remission-rate was found to be 10%, with much improve

ment obtained in an additional 37%.

In performing a

similar analysis on 2,000 metrazol-treated cases, Reit
man (49), reporting in the sa me year, found an average
rate of remission, for cases of less than eighteen

months' duration, exactly equal to that noted by Meduna

and ·Friedman; namely, 52%.

These figures, taken at face-value, would

lead one tocoonclude that the chances of effecting

a cure in any recent ease of schizophrenia are approx
imately one out of two.

Although they do indicate that

results obtainabl'e are inver_sely proportional to the
duration of illness, on closer examination, however,
I find good reason to take reports such as the ones

juet listed with a grain of salt, because of the wide

range of percentages entering into the calculation of
the above means.

It is common to hear the unthinking remark

made that "statistics can prove anything", whereas in
reality statistics "prove" nothing by themselves;
neither are they a substitute for common sense.

What

statistics_do accomplish is to describe a selection
of individuals from a large supply, and to present the
type, sprelid, skew, proportions, and relationships of
these individuals.

It is only by taking into considera-
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t1on all of these descriptive details that one can.

juatifiably make infe rences from the data collected.
In the case under disc ussion, a mean reco

veey rate of 52% means little, standing alone-.

Thia

can easily be illustrated by the following example:

Let us suppose that there_were a total of three·hoa

pitals reporting re�overy rates of, let us say, 50% ,
52%, and 54% , respectively.
52 %.

The mean rate would be

On the other hand, let us assume that the re

ported rates were 12%, 54% , and 90% , respectively.
The mean rate would still be 52%.

In the first ease,

we could infer, assuming that a large -enough number of

oth�r hospitals gave similarly concordant figures, that
any sehizoph renic whose illness 1s of a duration less

than eighteen months stands a 52% chance of being
cured by convulsive shock therapy.

In the second case,

we could infer nothing as to the effectiveness of the

therapy.

Rather, we would be led to conclude that there

ts a serious lack of uniform�ty in the selection of
cases, the criteria

or recovery, -the amount of psycho

therapy practiced, the technique used, the n'UJDber of
treatments given, or all of these factors combined.

That such· lack of uniformity does exist ia

obvious in the wide range of reeovery,ratea reported
tor convulsive shock therapy.

In Reitmann's report (49),
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(the one in Which he gave a mean recovery rate of

52%), the percentages of remissions as reported from

different hospitals varied from 7% to 100%.

Similarly,

Kennedy (50) noted, in 1939, that not only were there
great v�riations in the remission rate from year to

year, but that the total rates from different countries
ranged from 79% in Italy to 39% in Germany.
Selection of cases is undoubtedly one of
the moat significant of the factors causing these
statist ical discrepancies.

The data available in

which the case-material is cla�sified into types,

are scanty indeed.

Because ot this tact, about the

only way of forming an opinion as to the relative

efficacy of convulsive shock therapy among the va
rious types of schizophrenia is to take a poll of

a large number. o� hospitals as to thel·r -indications
for the use of the therapy.

This was done, as I have

mentioned above, by Kolb and Vogel (41), who noted

.

that most of the institutions reporting placed the

catatonic type high on their lieta of indications for
electroshock and metrazol, with the p�ranoid and hebe
phrenic types at the bottom of the list.

This is in

distinct contrast to the indications for in�ulin, as
noted by these hospitals; here, all these three types

stood at the top or the list of indications, with only
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the simple type at tpe bottom.

This being the case, it is possible to single
out the cause for almost consistently low percentages

of results with convulsive shock therapy, emanating from
state institutions (12, 16, 33, 40, 51), as contras ted

with the generally better results reported by private
psychiatric units and general hospitals.

For, accorditg

to Kennedy (50), paranoid cases, for legal reasons, are
more often sent to men't4.l hospitals than to psychiatric
clinics.

Thus there appears to. be one definit ely as

signable cause for wide discrepancies in results ob
tained.-

While on the �ubject of evaluttting convul

sive shock therapy as to types of schizophrenia bene
fited therefrom, it should be stressed at th1� point
that there seems to be .general agreement t?at Where
the manifestations of the disease are essentially

psychomotor or where there are well-marked affective
components, the response to convulsive shock therapy

is definitely favorable (2, 47, 50, 52, 53).
As mrght well be anticipated, the exper ience
of electroshock in the hands of various investigators
has repeated that of metrazol; namely, spectacular
results by the originators of the method, followed by
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an enormous range of recovery rates obtained by later
workers.

Cerlett1, one of the originators of electro

shock, reported 80%_ complete recoveries in his early
cases, Where the duration of illness was less than

six months (54).

A

sampling of other reports gives

an indication of the disconcertingly wide range of

result-s obtained:

Impastato and Almansi {55)
Ka11nows1cy and Worthing (24)
Gonda {l)
Neymann et al. (23)
Femphill (21)·
Smith et al. (22)

70%_

67%

59 %
47%.
4%.
0-,,,_

The causes for these 41screpanc1es can be
considered to be the same as those outlined under

the discussion of metrazol, since, as I have already

pointed out, the two methods can.be grouped together
wh�n considering the question of convulsive shock

therapy.

Some of the workers who have obt�iried high

percentages of good responses with electroshock are

convinced that the reason why the method has'not shown

equal effectiveness in other hands is that many workers
have used an insufficient number of treatments on their
patients.

Emphasis on this point was early laid by

Cerletti.

"In the disc�very of new therapies", he

remarked (cited in {56)), "the salient point is not

the type of treatment applied but the courage of the
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therapeutist in repeating the application again and
again."
This view has been stressed more recently by
Impastato and Almansi (55) and by Kalinowslcy (56), who

obtained excellent results in the electroshock treat
ment of schizophrenia.

Ka.11nowsky's stand is that sime

t�ere is agreement on the necessity of production of a
long se:raies of canai in insulin therapy, the same_ need

holds good tor electric convulsive treatment.

Fe admits

that the temptation toward abbreviation of the treat

ment is greater in the case of electroshoc, since most
schizophrenic patients with a reasonable chance of

improvement become tempora·ril7 free from symptoms
after a few eiectroshoc ks.

Such a procedure, according

to�Kalinowskr, accounts for the frequent statement that
schizophrenic patients treated by means of convulsions
usually relapse.

Th.at the number of shocks given� represent
a significant factor is indicated by a study of the 11-

terature on metrazol, conducted in 1941 by Ze1fert (57).

'Fis analysis revealed that results comparable to tho�e
in favorable reports on insulin therapy were obt�ined
onl1 by workers Who gave t wenty to thirty metrazol
treatments, even in those cases in Which early im
provement was obtained.
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Kal1nowsky and Worthing (24) gave ten extra

treatments to patients Who did not maintain improvement
after twenty electroshocks and found lasting remissions

to b� the result in many of these eases.

Because of

the beneficial effects of the adqed number of shocks,
Kalinowsky's present praet'ice is as foll.owa-(56):

Arter

twenty convulsions he keeps the pattent under observa
tion for at least three weeks.

An unsatisfactory result

is uaual.ly apparent within two weeks, when the contusion
clears up and residual symptoms bec�me recognizable; in

th�s event, ten more treatments are given.

It no deti

n1 te improvement is noticeable at any time during the
period of the first twenty convulsions, he considers

that further treabnent will not change the situation,
and he therefore discontinues the course.

It is Ka 

linowsky's belief th*t prolonged application of 'electro
shock therapy is useless for patients Who do not give

an earlf response, but he is convinced that it is im
perative tor patients who have shown the possibility
of a remission by favorable initial improvement.

Heymann and his co-workers (23) have not only

echoed Kalinowsk7 1 s views but have gone even farther,
recommending up to 45 or 50 shocks.

They suggest that

the patient should be treated until he is thoroughly
confused; then he should be rested and examined as to

- 66 inaj.ght,. at'ter orientation is re-established.

If

there is then no insight, they suggest giving the
patient another ser ies of treatments.
they give a third series.

It

necessary,

Whether such heroic therapy is always justi
fiable, it is difficult to say, since at the present
time we do not know to What extent the post-treatment
state of confusion is concerned in the mechanism of
recovery.

The fact remains, ·'·however, that 47� of the

patients 1n Neymann•s series of 90 electroshock-treated
schizophrenics were maintaining recovery twenty months

after treatment, When a follow-up study was done (23).
Even more remarkable, Neymann and his group found
that the recovery rate was greatest in their paranoid patients; the majority of other investigators,
as I have mentioned previously, have noted a very
poor response amor:g the paranoids.

A high rate of

recovery tor patients of this diagnostic type, 'similar
to the findings of Neymann and his group, was obtained
by Impastato and Almansi (55), who, like Neymann and
like Kalinowsky, also used a large number of treatments.•
The excellent results obtained by the use
of this intensive type of therapy appear to me as a
highly s1g�1f1cant clue for further investigation.

. - 67 If' other workers 1 n the future will be able to conf'i:nn
the above �indings by using intensive therapy on all

patients except those incapable of responding

to any

shock therapy, then it is not too unreasonable to

assume that electroshock may one day become the trea-t
ment of choice for all forms of t�eatable schizophrenia,

just as it is today, as we shall see in the next chapter,

for the affective psychoses.

At the present time there are hardly any

means of determining how extensively intensive electro�
shock therapy is being applied.

Kali�owslcy (56) dis

counts the sign1f'1cance of the average number of trea�•
ments indicated in some statistical reports because,
aoegrding to him, they usually include high values for
patients with hopeless, chronic illness Who received.

a long course of treatme nts, so that the average number
ot applications for the whole series was raised.

On

the other hand, he charges, treatme�t or patients with

a.good response, Who should have had a long course of
therapy, was discontinued after a few sessions, w hen
they were temporarily free of SJ]llptoms, and these
patients generally had a relapse.

In addition to these points, I have tound

that some workers become. too easily discouraged in
the electroshock treatment of recoverable eases.

,,.
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�emph111 (21), for example, expected. his patients to
show some improvement before the fifth convulsion
in order to �e classified as recoverable.

Th.ere 1s

little cause :tor wonder, then., that he succeeded in

producing only :tour recoveries out of a total o:t
114 schizophrenics.

While on the subject o:t intensive therapy,
it should be mentioned. that a large factor 1� the
production of discrepancies in results can-probably

be assigned to the differences between investigators

in the technique of the individual convulsion; 1. e.,
the question of gram mal versus petit mal seizures.

Because of the fear of damage to the patient by grand
mal convulsions (a question which will be taken up in

a later-chapter), some workers have u�ed a subeonvulsive

dose o:t current in electroshock therapy.

By now, how

ever, most writers are agreed that grand mal convul

sions are es$ential in order to produce good results.

Androp (78), for example, in contrasting the results
obtained in schizophrenia on two different groups of
patients, one group treated with convulsive doses,

the other with subconvulslve, found a 14% higher im
provement rate with the former technique.

It 1a quite

possible, then, that the use of the subconvuls1ve
method by some workers has contributed in part to the
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reporting of unfavorable resu1ts.
In view of the fact that the amount of
perseverance ex,hibited by most investigators in
the convulsive ·shook treatment of schizophrenia ls
a matter for surmisal, not to mention the fact that
many workers do not even take the trouble to classify

their cases by types in their reports, there is little

value in accepting data on cases treated by both con
vulsive shock and insulin shock simultaneously or

in series.

A combination or the two methods, or the

use of one method after failure with the other, has
been practiced by various workers since the early

days of insulin and metrazol.

Meduna, in 1938, ex

pressed his opinion on this point (7):

"Special attention is due to those eases

Who do not respond to one method ot treatment but
are cured by the other.

This very important f'inding

seems to me to show clearly not only that the mechanism

of the cure involved in the two methods is 41frerent
but also that at least two forms of sch izophrenia,
with different pathological mechanisms, must exist.

Hence the importance of the fact that two d1f'f'ere nt
therapeutic methods are at our d isposal.

Cases that

show resistance to one of the two methods but later
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reapond to the other, I call •crossed eases•.

I am

fully cQnvinced that �ndocrine studies of these crossed
forms will 1ift the veil that still hangs over the na
ture of schizophrenia.

For both methods, a knowledge

of the nature of the biological events going on in the
organism during the treatment, and their chronological
sequence, is of the greatest importance."
'!'here have been many reports of such "crossed

cases", and many different me thods of combining or al
ternating the two methods have been uaed.

Taylor (27),

for example, has recently reported that he gives insulin
to all types of functional psychoses and neuroses.

after twenty insulin treatments the pH-tient does not

If

show decided improvement, then electroshock 1s added

to the treatment. Weil and Moriarty (20), on the o ther

hand, prefer to start with electroshock iri all cases of
schizophrenia, since this method alone may beJsuff1c1ent, and, according to them, it seems to have a time

saving effec t if a subsequent course of insulin treat
ment is necessary.

Goldstein, Dombrowski, and Fd.lin (58)

reversed this procedure by administering metrazol to
patients Who remained unbenef1ted with insulin.

:Ewen (59}

combined electroshock and insulin from the start on a
group of his patients.

Botkin and his co-workers (26), in reporting
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on 40mbined treatment, indicated. that their rate of
improvement was considerably greater than they had
previously obtained with convulsive shock alone.
They also analyzed their cases according to •type and
found that, in the improved group treated with com
bined hypoglycemic and convulsive therapy, the para 
noid and the catatonic types were equally represented.
Ewen (59) found that his paranoids :fared better than
either.bis catatonics or his hebephrenics.
These·observations are interesting in vi ew
of the general experience that paranoids as a group are
resistant to convulsive shock therapy alone.

Ta7lor's

experiences in this regard are more in line with this
general observation.

In cond.ueting a five to seven 7ear

follow-up study (39) on a group of his patients Who had
all been treated by the combined method, he noted that
no� only did the simple, catatonic, hebephrenic, and
mixed types respond better to the treatment than did
the paranoids but also that the paranoids had the
highest rate of relapse.
Of Taylor's original group of 214 treated by

insulin and metrazol combined, there was a recovery rate
of 71.5% at the end of treatment.

Today, following re

lapses during the five to seven year period, this figure
has been reduced to 58.6%.

-- 72 One is led to wonder, judging from the fa

vorable results ob tained by the proponents ot intens

ive convulsive therapy, if Notkin's results, outlined
on the previous page, might not have been equally as
good had he used a prolonged course of convulsive

shock alone.

Al though he found improvement in 37%

of his combined-treatment cases, he reported none ot
them as recevered.

Is one to assume from these re

sults that the combined-treatment is impossible of
producing recoveries·?

otherwise.

Taylor's _series im1cates

Since 83$ o� Notkin's treated patients

had had a psycho�is for ov�r eighteen months, is

there the poasib111ty that these really!!:!. mere

improvements and not full recoveries?

or, would a

case whGm Notkin considers improved be clas sified
by other workers as recovered?

Here again, one sees

the crying need for the general adoption and use of
a definite set of criteria for grades of recovery.
In summary, the role of convulsive shock

therapy in the treatment of schizophrenia can be
stated as follows:

T.hus far convulsive shock therapy has shown
1tselr to be of greatest value in the treatment -of the
catatonic type

or

schizophrenia and in cases where there
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is an at'feotive component in the clinical picture.

In all other types, more favorable results have been

produced by hypoglycemic shock therapy.

This division

of indications is to be regarded, however, as only a
very rough guide.

Many patients respond to a combina

tion of both methods Where the use of one or the other
had preY1ously failed.

It is possible that in the

future further investigation.will substantiate the

claims of some workers that failures with convulsive

shock therapy are due not to the therapy itself but

to•inetfective, half-hearted application of it, since
all those who have subjected their schizophrenics to
prolonged, intensive courses of treatments, have ob

tained, in recoverable cases, more gratifying results
than those who have not used this technique.

In the absence of an adequate number of follow�

up studies covering significantly large groups of patients,
it is impossible to detenn1ne statistically the long-term

effectiveness of convulsive s hock therapy in schizophrenia.
This being the case, possibly the wise thing to do is to

accept the conso11ng'thought expressed by Bond and Rivers
(36):

"Perhaps in the final analysis the years of health

given to these cases are more important for the indivi
dual patients involved, the family groups in Which tpey
are functioning, and therefore for society in general,
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than are final statistics concerning the number re
covered or relapsed at the end of an arbitrarily

sele cted time period."

Chapter III
The Shock Therapies
iri the Af'fective Psychoses
In the early years of the shock therapy era,
the tocus of attention was directed practically en

tirely on schizophrenia, since this was the disease

Which had occupied the efforts of the originators of
the hypoglycemic am convulsive methods.

It was not

until 1938 that evidence began to appear concerning

the use or shock therapy in the affective psychoses.
In that year Cook and Ogden (62 ) were 1m

preased with. the favorable results in cases of schizo
phren�a Which showed depressive features, as well as
in a small series or eases of clear-cut affective
disorders.

In the same year, Low and his co-.w orkers

{63) reported the effective use of metrazol in a series

of manic-depressive"patients.

They noted that despite

a duration of illness·ot more than two years in six
of their patients, five of these recovered.

The most

gratifying or these earl7 reports was that of Bennett
(64}, who, also in 1938, reported the termination of

severe depressions in 21 patients, by the use of an
- 75 -
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average of 5 metrazol convulsions.
Since the publication of these initial re
ports, impressive
convulsive
has come

confirmation of t1,e erficiency or

shock therapy in tre affective psychoses

from a host of investigators.

Tbe hlgh

degree of uniformity of good results is evident in
the following examples of reported recovery rates:
Young and Young (65)
Cottington and Gavigan
(66) Bennett (67)
Eba.ug1� and Jo1-inson (68)
Wilson (69)
Cronick (70)

Cummins (71)
Ziskind et al. (72)
Because of the

95%
85%
90%
87%,
76%

93%

91%
89%

success of convulsive shock

therapy in the affective psychoses, and since this
method is a. much simpler procedure than is insulin
shock therapy, convulsive shock has long been regarded
as the method of choice in treating the affective psych
oses.
In the pre-shock era, all forms of chemical
and endocrine met'liods had been tried in the treatment
of the affective psychoses, including hematoporphyrin,
estrogenic, testicular, or pituitary hormones, and
narcosis; even fever t'l-ierapy "1ad been used.

In none

of these had any consistent effect i� shortening the
course of the psychosis been observed (64).
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contrasted with the ineffectiven ess of these methods of
the pre-si,ock- years, is obvious in a study conducted by
Bennett and Wilbur (74), in which 64 patients wi t'
involutional psychoses, who had previously received
varying amounts of estrogenic hormones without benefit,
were treated with convulsive shock therapy and
psyc:i-:iotherapy; 90% of this group showed social or full
recovery in 4 to 6 weeks.

Since some patients in this

group had been 111 for more t han a decade, it could be
said that t'bey served as their own controls.
There have been some, however, who. have
minimized the value of the therapy on the grounds
t�at the affective psychoses represent essentially
benign conditions which have a generally favorable
prognosis regardless of treatment.

Kennedy, for

instance, statea (50), "Convulsive t�1erapy is unlikely
to have any specific effect on the affective
psychoses but is able sometimes to determine a fa
vorable change of mood in cases where such a change may
be expected to occur sooner or later".
That sue}, a viewpoi_nt is ill-considered is
indicated by the results of studies in which patients
having affective psychoses and treated with shock have
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controls.

Tillotson and Sulzbach (73), for example, in

conducting t�is type of study in 1945, found that
s�ock treatment not only accelerates remissions but has
an independent value.

They performed an 18 to

45 mont... follow-up observat ion on a group of 70
electroshock-treated patients and 68 controls and found
that 80% improved under shock therapy, aa against
qnly 5u%

for the control group.

Furtl-Jermor e, .four

of their patients who had been riospi talized with un
relenting depressions for five to fif teen years
recovered fully in three weeks to four months after
the beginning of shock treatment and had maintained
their recovery at optimal level for at least two years
and three months.

As in the report of Bennett and

Wilbur (74), these p, tients served as th.eir own con
0

trols.
In addition, speaking qualitatively rather
than quantitatively, Tillotson and Sulzbach claim that
some of their shock-treated i:e.tients display a far more
efficient intellectual

ctS

well as emotional adaptabi

lity to their environment than ever before in their
lives.
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By using the statistical technique of com
puting the standard error of tne difference between two
proportions (see page 49}, I calculate that the chances
of the quantitative difference reported by Tillotson and
Sulzbach being due to randomness are
of the order of 1 in 5,000.

Over and above this

significant increase of recoveries among shock-treated
affective psychotics as contrasted with controls, the
efficiency of t�e therapy in shortening the length
of hospital:tzetion is, as we found it to be in the case
of schizoprrenia, a matter which can not be lightly
dismissed in considering the value of the treatment.
Tillotson and Sulzbach found that the average 1 ength of
hos pitaliza tion in their control group was 21 months; in
their treated group, the average length of hospital
residence as computed
from the time of the first treatment was only 1 month
and 26 days.

This difference is, of course, tremen

dous 1 amounting to a 75% to 90% shortening of hos

pitalization by the use of shock therapy.
Similarly, Bennett (53), in reviewing cases of
recurrent types of manic-depressive paycboses, found
that the average duration of illness, including hospi
talization, in the years before t'r.e onset of the s'hock
therapy era, was six mont�s, as contrHsted with an ave-
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rage duration of two months in cases treated with shock
trerapy.
After the introductio·n of electroshock, this
form of therapy, because of its obvious advantages over
metrazol, as pointed out in the previous chapter, began
to be regarded as tre method of choice in tre treatment
of the affect i ve disorders.

The rapid acceptance of

electroshock therapy by the profession is indicated by
the -'-act that whereas at trie end of 19;:;9, only 3 of the
305 hospitals in the survey of Kolb and Vogel (41) were
using t'bis method, it was reported as being used two
years later by 256 hospitals in the treatment of manic
depressive psychoses and by 216 in the treatment of the
involutional states.
A survey (75) of the results of electroshock
therapy appearing in the literature up to 1942 gives
evidence of tre e1fectiveness of the treatment in the
affective psycroses.

A combination of the findings of 28

different autrors showed that out of 158 involutional s
treated, 69% recovered and 20.2% improved and that out of
a total of 596 manic-depressives, these rates were 59.5%
and 27.8%, respectively.
Although surveys such as this one are useful
in giving an over-all picture of the affective psychoses
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find variations in effectiveness of the treatment among
the various forms of these psychoses.
In the survey of Kolb and Vogel (41), it
was found that, in the majority of hospitals reporting on
their specific diagnostic indicat ions for the use
of electros 'h ock therapy, involutlonal psychoses topped
the 11st; the other affective disorders followed closely
in their list of indications, the manic-depressive
deyressed state being second, and manic-depressive
manic
.fourth ( third place was held by catatonic schizophrenia).
In line with this order of indications, many
investigators have found that manics usually require a
more intensive therapy than do depressives.

Kalinowsky

(56), for example, (who, it will be recalled, is one
of the leading advocates of intensive electroshock
therapy for schizop'l-irenia), noted that the usual number
of 8 or 10 treatme�ts given for depressions is not suf
flc lent to maintain 1 ·,provement in manic patients.
The necessity fbr the induction of 2 0, or even more,
convulsions in some manic patients led him to apply
more intensive treatment by means of two or three
convulsions daily.

By the use of this technique he found

it possible to break up severe manic excitements by a
course of five or six convulsions, instead of the
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u sly.

T-Te also found

that patients with cyclic states, with constant shifting
frum one phase to the other, did not benefit from the
therapy.
A difference between subtypes of psychosis even
more pronounced than between t½e manic and the depressed
manic-depresslves is noticeable When analyzing the
subdivisions of involutlonal psyc"lrioses.

Kalinowsky found

that alt"1ough the recovery rate for pb tients w 1th
invvlutional melancholia was 86.9%', it was only 43.7% for
those wi t'I-J t':1e paranoid type of' involutional psychosis.
The difference in the number of treatments required was
similar to the difference between depressives and manics.
Involutional melancholiacs usually received 8
treatments, whereas patients with the paranoid type
usually required at least 20 convulsions.
Another point of difference is notable in
considering the effect of t'-,e duration of the disease on
the final thera:peutic outcome.

It will be recalled that

in the early report of Low and his coworkers (63),
recovery was obtained in manic-de pressives whose dura
tion of illness had been greater than two years.
Similarly, Tillotson and Sulzbach (7�) found, in analyz
ing the prognostic factors in the trea. tment, that the
chronicity of illness had no bearing on the recovery

of their cases; also, that the role played by previous
attacks was negligible.

As previously mentioned, four of

their patients, who had been hospita lized with depressions
lcsting five to fifteen years, made a complete and
apparently permanent recovery in three weeks to four months
after the first shock treatment. In Bennett's
original series of affective psychotics treated by con
vulsive s1,ock (6'7), t11.e rs.n12;e of duration of illness for
recovered p�tients was 1 week to 6 years for the
depressed manic-depressives and 1 week to D years for the
involutional melancholiacs.

Even more noteworthy, re

coveries have taken place in involutional melancholiacs
whose duration of illness was as long as 12 years, as
reported in the series of Bennett and Wilbur {'/4).
Thus we find that, in gratifying contrast
with the question of tree,ting sch izopbrenia, the fac- tor
of duration of illness in the manic-depressive psych
oses and in involutional melanc'l-\olia has no bear:i.ng on
the outcome of the treated disease.

It was noted by

Kalinowsky (56), however, that the outcome in involu
tional paranoids is, on the other hand, largely
dependent on this factor.

It will be recalled that in

the discussion of schizophrenia the Doint was noted
that those schizophrenics in wriom there is an affective
component

in the clinical picture respond better to
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therapy than do those who are largely devoid of af
fect.

It is interesting to compare this wi t h the

observation that involutional psychotics of the para
noid type are comparatively unresponsive to treatment
and, in contrast to involutional melancholiacs, depend
for their prognosis upon the duration of 111- ness.
These facts tend to indicate that the prog
nosis of a given psychosis, treated with shock therapy,
is directly proportional to the ratio of affective to
schizop....,renic components in the particular patient in

question.

Concerning other prognostic factors in the
shock treatment of the affective disorders, Tillotson
and Sulzbach (?.:,) found that the balance of assets and
liabilities in the make-up of the pre-psychotic person
ality is usually a favorable one in cases with good
response to therapy.

�owever, according to them, the

correlation coefficient between favorable pre-psychotic
personality and favorable resronse to therapy, While
being on the positive side of zero, is not great enough
to be statistically si�nificant.
Another prognostic factor to be taken into
consideration is the number of treatments require d.
Tillotson and Sulzbach not e thut tris number does show

- 85 -

an inverse relationship to the eventual degree of
improvement.

Thus, improvement in tl-Jeir cases u sually

became noticeable after as few as two treatment s in pa
tients with eventual recovery.

If no beneficial re

sults were evident with 8 or 10 treatments, invariably
no therapeutic gain was achieved by an additional num
ber of treatments, and relapses from transitory
improvement failed to show better results on resumption
of treatments; in fact, according to them, subsequent
imrro vements were usually of less degree.

Although the observations given by these
authors relate to the affective psyc�oses in general,
1t will be recalled that, despite the fa.ct that Ka
linowsky (56) found it necessary to adminlster more
treatments to his manics than to his depressives, and
more to his involutional paranoids than to his invo
lutional melancholiacs, still he noted the possibil:t ty of
obtainin� recoveries in these more resistant types after
the applic1-ction of approxim 01tely 20 shocks.
All of wh.i ch tends to •indicate tl-tat a therapeutic method
which results in failure in some hands is successful in
others, and tbat one can not rely too heavily on the
results obtained by any one group of investigs tors. alone.

As in the case of schizophrenia, the majority
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or investigators lay great stress on the desirability,
or rather the necessity, of using shock therapy as an
adjunct to psyc'!.-.iotherapy in the treetment of the af
fective psychoses.

As one writer has stated (77),

"A grave injustice is done to any patient who does not
receive intensive psycl7ological assistance whenever
possible.

By intensive, I do not mean one or two

superficial interviews but a persistent
investigation of those factors in t"e functioning of
the peraonality which led to ti_.,e mental breakdown.
Thia therapeutic co-ordination assures a healthier
individual, less likely to break down again in a
critical situation".

As another author (1) puts it,

"It is not ov-erstating the case to say that intensive
psychotherapy is almost as important as tbe
elicitation of the convulsion itself."
There are some workers, e. g. (42), who go
even farther in this regard and consider the
therapeutic function of shock therapy as being only a
meana of rendering th e patient responsive to
paycbotherapy, which, according to them, accomplisbes
the real cure.
The t�erapeutic relationship between shock
therapy and psychotherapy appears to me, from these
reports, to be analo�ous to the relationship between
opsonins and leucocytes in the body-defenses.

The

- 8? manner in w'hich the two forms of therapy are inter
related has been analyzed by Levy and Gr inker (81).
In discussing depressions in particular, they state,
"The major obstacle to psychotherapy of depressed pa
tients is the strong repression of all but the self
punishing tendencies.

The ego, which customarily co

operate.a with the psychiatrist in the task of
un:lerstating and modifying the emotional conflicts, is
usually overwhelmed and subjugated by the punishing
super-ego.

The inhibited, retarded, depressed or the

depressed, agitated patient, completely pre-occupied
witi, c;elf-punish i.ng :t'a ntacsies, presents almoat impe
netrc:ble resistance ag�tinst psyc,.,, otherapy.

Exper ience

with shock t"1erapy shows that these resistances and
rerreasiona can be sufficientl y influenced to permit
release of repressed feeling and impulses into motor
activity, verbally expressed thoughts and feel ings, or
fantasies and dreams.

In some cases this may even lead

to conscious insight into deeply repressed emotio nal
conflicts, a discussion of wt>ich may bring about sig
nificant changes in certain basic emotional attitudes. n
Not all are agreed, however, that psychotherapy
is indispensable.

Kalinowsky, for example, omitted

psycbotherapy in 200 patients with affective psychoses
and yet obtBined an 86.6% recovery-much improved rat e
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with electroshock therapy.

Nevertheless, regardless

of these results, the consensus is that psychotherapy
following a course of shock treatment is the most effective means of maintaining recovery and of assuring
the patient a better adjustment than can be attained
by the use of shock alone.

Another problem concerning technique of
treatment which has been largely settled by now is
the question of grand mal versus pet1 t mal reactions.
As in the case of schizophrenia, noted in the previous
chapter, it has been shown that grand mal seizures are
essential for the production of good results in treating the affective psyc~oses.

Gottesfeld and his co-

workers (79), for example, obtained an improvement
rate of zero on using subconvulsive electroshock on
a series of such p8tients.

Wnen repeating the treat-

ment with convulsive doses of current, they secured
a recovery and improvement rate of 28.7%.
Similarly, Ziskind (80) found that su.bconvulsive reactions are not only useless but harmful,
even though followed s'!1ortly tl:'lereaf'ter by a convulsion.
Pis results on affective psychoses treated with metra-

zol showed a near 100% response in the cases having
no petit mal reactions.

Not only were there therapeutic
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failures in his group with petit mal reactions, but
these failures were increasingly greater in proportion
to the percentage of such reactions.

Findings such as

these have convinced most investigators that nothing
is to be gained from the use of subconvulsive methods,
and so today the production of grand mal convulsions
is, by general agreement, considered imperative.

We have seen that the immediate results of
shock therapy in the affective psychoses, when the

-

treatment is correctly applied, are uniformly excellent.

However, since the crucial test of any therapy

is the permanence of its beneficial effects, we must,
as in the case of sch izo;hrenia, resort to an analysis
of long-term follow-up studies to determine the ultimate
value of the treatment.
Ziskind and his co-workers (72) conducted
this type of study for a period ranging from 4 to 40
months, averaging 22 months.

Fifty-nine treated cases

and 74 untreated controls were considered.

The imme-

diate recovery rate for the treated group was 89%,
as contrasted with a rate of 46% recoveries among the
controls.

Relapses occurred in 11% of the patients

discharged as full recoveries; however, new attacks
were twice as frequent in the untreated as in the
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treated group.

I note that 37 o.f t.re '74 controls

had mild symptoms and were therefore given no shock
therapy.

In view of this f2ct, the significance of

the difference in relapse rate between the treated

I
I
II

i'.

I

group and the controls becomes even greater, since
the control group, half of whom were only mildly
psychotic, produced twice as many relapses as the
treated group, all of whom had symy;toms severe enough
to require shock therapy.

This would tend to indicate

t~at shock therary in t½e affective disorders has an
indefendent value over and above a mere acceleration
of recovery.
Another well-controlled study has been done
by Tillotson and Sulzbach ('73), who observed a group of
70 treated patients and 68 controls over a period of
18 to 45 months.

The immediate recovery rate in their

treated group was 80%, as contrasted with 50% spontaneous
recoveries among the untreated group.

At the end of the

first year after discharge, the rate of failures and relapses was 17% for the treated cases and 40% for the controls.

Of all the recoveries in the shock-treated group,

the manic-depressive depressions had the highest absolute
rates, but relatively higher gains were accomplished with
regard to the cases of involutional melancholia.

The

difference from the controls was 38% for ti,e manic-depressives, whereas it was 52% for the involutionals, thus

i
i:

~'
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indicating a 1-iigher relative effectiveness of shock
therapy over non-treatment in involutlonal melancholia.
As in the consideration of sc~izophrenia, I
find it hazardous to regard many figures
obtained in
~

follow-up studies on tr.e affective psychoses as being
statistically significant, the reason being the same
as it was in schizophrenia; namely, that in many cases
not enough of the original ~roup of discharged patients
are avail2ble at the time of the follow-up study to
be able to draw justified conclusions concerning the
entire oriqinal group. (This is particularly evident
in the report of Smith, Hastings, and Hughes (76).)
Because of th~ small size of tte total number of affective psychotics who have been observed for long
periods of time following treatment, it is difficult
to derive any more than a roughly accurate idea as to
the ultimate value of shock therapy in the affective
disorders.
Significant factors in the production of
sustained results seem to be the amount of time that
the shock-treated patient is kept in the hospital and
the number of shocks received.

Bennett (53), in con-

trasting a group of relapsed patients with a control
group who had remained well, after treatment, for from
2 to 5 years, found that the former were held in the
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hospital on an average of ten days less than the latter.
Also, the relapsed p'.:,tients averaged 5.5 treatments,
whereas the controls, who cad not relapsed, were given
a mean number of 7.2.

From this, it may be concluded

that adequate treatment and a sufficiently long period
of hospitalization (Bennett considers six weeks as the
optimum time) provide reliable assurance for the maintenance of the patient's recovered status.

In conclusion, the role of shock therapy in
the affective psychoses can be summarized as follows:
The therapy has consistently brought about
uniformly gratifying recovery and improvement rates,
even in cases of long duration.

Electroshock is the

method of choice today, and good results are obtained
only by producing grand mal seizures.

More intensive

treatment is required for manics than for depressives
and for involutional paranoids than for involutional
mela.ncholiaca.

However, with adequate therapy these

more resistant psychoses are capable of giving a good
percentage of responses.

As evidenced by comparison

with non-treated controls, the therapy produces not
only better immediate results but also more sustained
improvements.

As in the consideration of sc,-,izopbrenia,
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shock treatment of the affective psychos~s produces

best results when used in combination with psychotherapy.

J[
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Chapter IV
The Shock Th_eraEies
in the E!!zchoneuroses
Al though the shock therapies have found
their most extensive field of applic~tion in the
major psychoses, they have also been used (albeit
grudgingly, it appears) in the treatment of the
psychoneuroses.

Unfortunately, most of the results

of shock treatment of the neuroses appear usually
as reports on mere handfuls of cases, appended to
articles dealing mainly with the major psychoses.
One regrets to note that the trial given the therapies
in tre neuroses has been on such a small scale that a
quantitative statistical analysis of the results obtained is not warranted.

Nevertheless, on the basis

of the findings in a limited nu.mber of cases, one is
ju~tified in forming a quelitative estimate of the
sphere of usefulness of the treatment in these conditions.

Myerson (82) reports success in dealing
with a number of borderline mental states which,
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according to him, yielded not in the least to other
fonns of therapy, including long p~riods of psychotherapy.

~is cases included patients in whom there

ap1,-eared profound alteration in conduct, marked disturbance in mood, failure of energy, anhedonia, actual
and severe depression, and industrial and social incapacity.

The majority of these cases benefited mar-

kedly after a few electroshock treatments.

Since this

group had remained unbenefited by other forms of treatment, one is led to agree wit~ Myerson 1 s conclusion
that in such borderline conditions tre pbysical therapy involved in the shock treatment is superior to
any other form of therareu tics, including psychotherapy.

Concerning the use of shock therapy in
clearly-defined psychoneuroses, one of the earliest
reports on the question was that of Shapiro and Freeman (83) in 1939.

Tr.ese investigators noted that

neurotic patients usually require fewer doses of metrazol than do psychotic patients in order to cause subsidence of their symptoms.

Some of their neurotics

were completely relieved of their preoccupations after
one or two convulsions.

Vowever, they usually continued
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treating them until a series of 6 to 12 shocks had
been given, or whatever number was found necessary
to produce forgetfulness and confusion.

It was found

by these writers that chronic cases often proved amen-

able to treatment, alt~ough prolonged fixations, either
psychasthenic or hysterical, reacted unfavorably.
The patients treated by Shapiro and Free.man
included cases of obsessive-comrulsive neurosis, anxiety neurosis, reactive derressions, conversion hysteria,
chronic tension states, post-traumatic neurosis, and
cr.ronic alcoholism.

Their best success was obtained

in tlie obsessive-compulsive and conversion hysteria
groups.

Out of 7 patients in the former group, 5 re-

covered, 1 improved, and 1 failure was noted.

In a

series of 5 cases of conversion hysteria, the treatment resulted in 4 recoveries, 1 improvement, and no
failures.

Their equally small number of cases of

anxiety neurosis, recJ.ct ive depree: s1.ons, and cl-ironic
tension states reacted somewhat less favorably.

The

only groups in which complete failure WHs-obtained
were post-trauma tic neurosis and chronic alcoholism
(only one case of each of these two types was treated).
Sine e the number of patients in each of the above diagnostic categories is so small, conclusions can not be
drawn from this one study alone.
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The findings of J{alinowsky (56) and of
Sagebiel (118) agree with the above in regard to the
obsessive-compulsive neuroses.

Kalinowsky feels that

shock-tnerapy is justified for severe and chronic

~
V
,,1

cases in this group, when psychotherapeu.tic methods
have failed.

Ve notes, however, that although ob-

sessive thoughts or compulsions may disappear or become less troublesome duriug the confusional state of
a long course of electroshock treatments, they usually
return shortly.

AltMough Kalinowsky's report was pub-

lished in 194~, he noted that t~e usefulness of shock
therapy in the psychoneuroses had not yet been estab1 ist,ed.

ve had treated 50 neurotics and found that

favorable responses occasionally occurred but realized

that t½ey were too rare to warrant routine recor:nnendation of the t~erapy for the neuroses except, as mentioned above, for chronic and severe obsessive-compulsive
neuroses unyielding to psycho the ra.feutic methods, and
also for psychoneurotic depressions.

Good results in

the latter condition have also been reported by Myerson (117).
The most favorable report of any I have found
is that of Moriarty and Weil (119), who obtained recoveries in 10 out of 20 electroshock-treated neurotics, with a.n additional 9 being listed. as much improved.

!
l
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Their cases were composed mainly of anxiety hysterias
and psycl-iasthenias.

!/!oriarty and Weil contrasted these

results with those observed in 79 controls, who had received no form of shock therapy.

In this grouf, only

7% were considered to be recovered on discharge, while
71% were pronounced much improved or improved.

~

-~

That the good results obtained by these workers in their small series of cases are the exception
rather than the rule is evidenced in a review, contained
in their report (119), of the findings of 14 authors
reporting on ti-,e use of s,,_,ock therapy in the psychoneuroses.

r:rere, out of a total of 130 shock-treated

!
!
I

neurotlcs of all types, only 36 cases (28%) were described as cured.

In the regrettable absence of a sufficiently
large number of ca3es on which to form quantitative
conclusions, one has little to go on except general
impressions, such as given by Proctor (42), who, in
surveying the indications for shock ti-iera.py, has recently
expressed full agreement with the findings outlined previously; namely, that shock therapy is occasionally indicated in cases of the obsessive-com;~ulsive type of behavior and in the hysterias, when these cases have not
responded to at least three months of energetic psycho-
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therapy.

ne adds, with apparently justified pessimism,

that one should realize, on attempting the treatment,
that recovery is unusual.

Concerning the relationship between shock
therapy and psychotherapy, it ls interesting to note,
in contrast to this ~.spect of the problem in the case
1

of the major psychoses, how little faith is put by
some workers in the use of shock treatment as a therapeutic adjunct in the neuroses.

Kalinowsky (56), al-

though he grants that the patient's increased accessibility can be used to advantage for a better psychotherapeutic approach, feels that the occasional helpfulne:-,s of shock treatment in the neuroses as such an
adjunct cannot be considered comparable in type or
degree to the improvement which can be achieved by its
application in the psychoses.
Shapiro and Freeman (83), on the other hand,
assume an almost nihilistic attitude in regard to postshock treatment psycl-Joth erapy.

Their stand is that any

suggestion by the physician of the psycho-pathologic
sources of t~e original conflict is distasteful to
psychoneurotics and serves to encourage introversion
and pre-occupation.

They actually dissuaded their pa-

tients from exploring the causes of their illness and
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persuaded them to indulge in physical activity in a
further attempt to dissipate emotional tensions.

For

intensive psycl"otherapy they substituted "encouragement and gentle re-education".

To my knowledge, Sha-

piro and Freeman have not conducted any follow-up
study on their patients, and it is therefore impossible
to assess the permanent gain to be derived from a program such as this.
A more ort~odox view, and one w,,ich is more
in line with the majority-opinion presented in previous
chapters, has been expressed by Moriarty and Weil (119),
who feel that shock therapy prepares the ground for
psychotheraiy by improving the affective tone, fostering
act 1ve co-operation and tending to over come the "repetition compulsion".

They advocate the subsequent use

of psychotherapy to permit the patient to gain understanding and inner fortitude, as a ,;i;uard against relapse.
Even Shapiro and Freeman (83), whose results
in the neuroses, it will be recalled, were not unfavorable, are conservative in their estimates of the total
good accomplished in these disorders by the use of s'hock
tterapy.

After stating their results, they hasten to

add that they do not clai!Il that the personalities of
their patients are altered or that ti,eir difficulties
have been forever done away with.

They do feel, though,
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that the majority of the patients treated by them no
longer suffered from the complaints that caused them
to seek psychiatric help.

In contrast to the limited usefulness of
shock therapy in the neuroses of civilians, the treatment has become a valuable weapon in dealing with the
neuroses encountered in military life, caused by battleconditions.

Evidence for this is to be found in the

survey (84) by Grinker and Spiegel of the handling of
war neuroses in the Tunisian campaign of 1943.

Their

indications for the use of shock th'3rapy are best expressed in their own words:
"We have been slow in usi~g shock therapy
in this theater of operations, because we believed
that persistence in 'u.,."lcovering' technics, which aim
to bring repressed emotions to the surface, would ac-

complish much more in the way of permanent good to the
patient.

\'!e

also wished to avoid ot..,ers being exposed

to t~e temptation of non-psychologic short-cuts in
treatment.
"It soon became apparent that many cases
suffering from clinlcol depression, or other mani-
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festations of repressed ~ostility, did not respond
well to pentothal treatment (narcosynthesis) or psychotherapy in the time available to an individual patient.
Yet we wanted to do something for these patients promptly,
since they are the ones who quickly attain a state of
chronicity and rigidity, and become so difficult to treat
after return home.

Therefore we began the cautious use

of convulsi'Je shock treatment, after pentothal inverviews and psychotherapy had accomplished all that was
possible.

We followed t'be shock treatment with adequate

psychotherapy before transferring or evacuating the patient."
Thus it is evident that, in the handling of
war neuroses, convulsive shock tl-ierapy is valu:ble as
a last rPsort When other, more conservative, methods
fail.

Grinker and Spiegel present two cases as ex-

amples of the good results obtained with the trerapy
in such instances.

To summarize the role of shock trerapy in
the psycQoneuroses, it may be said that, despite the
absence of any large series of reported cases, one
may conclude that the therapy has little value, except in war neuroses, psycnoneurotic depressions,
obsessive-compulsive and hysterical states, and in
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borderline states between the neuroses and the psychoses.

In all of these conditions s~ock therapy is

indicated if the patient has proved resistant to more
conservative methods.

For the majority of psycho-

neurotics, psychotherapy continues to be the treatment

or

choice.
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Chapter V
The Hazards
of the Shock Therapies
An evaluation of any new form of therapy is
dangerously incomplete if it fails to take into consideration not only its assets but also its liabilities.
There are numerous methods of treatment used in every
field of medicine which can be ~~mployed wisely only
if due regard is given to t~e dan~ers involved in their
use.

There are others whose disadvantages far outweigh

any therapeutic benefit to be derived from their administration.

And certainly, in a form of treatment as

drastic as shock therapy, it would indeed be folly to
endorse the method before investigating the price paid
in bodily damage by its use.
The recognition of the risks involved in
the shock therapies has led to t'l-:leir unmerited discredi tment in some quarters, and the terms "brutaln and
"sadistic" have not infrequently been used in descriptions of t'b em.
Complications involving either life or limb
were noted very early after the inauguration of the
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treatment methods.

Kinsey (85), in 1941, surveyed

all the published cases on deaths resulting from the
shock therapies and found the incidence to be 73 per
10,000 patients treated with insulin, and 23 per 10,000
treated with metrazol.

The death-rate of electroshock-

treated cases has been estimated by Kolb and Vogel (41)
to be 5 per 10,000 patients.
In his report, Kinsey analyzed 46 metrazol
deaths.

Of these, 21 were attributed to pulmonary

complications.

Twelve of these were the result of

pulmonary tuberculosis activated during treatment.
Three deaths resulted from pulmonary infarction.
There were three cer~bral deaths, two due to hemorrhage
and edema.

Status epilepticus was also noted as a

cause of death.

In considering insulin treatment,

it was found that hypoglycemic encer"1ali tis was the
cause of 38 deaths.

Since t~e s~ock methods are therapeutically
directed against the central nervous system, one might
exrect the greatest amount of post-treatment damage
to be found there.

Numerous experimental and human

autopsy studies have been undertaken in attempts to
study this phase of the question.

Tl-,e pathological

effects of insulin treatment on the human brain were
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studied by Ferraro and Jervis (86), who noted fatty
degeneration of the neurons and an increase in intracellular lipoids, particularly in tbe temporal lobes.
They also found chromatolysis and, in the cells in the
region of the blood vessels, ischemic changes.
In a later report (87) or additional insulin
cases, Ferraro found zones of rarefaction in various
cortical areas, due apparently to the gradual disappearance of affected nerve cells, as well as the
absence of eel.ls in patchy, focal areas where they
had undergone degeneration and disintegration.

Also,

there were areas of cortical devastation involving
various layers, with disturbed cortical cytoarchi-

!

I
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I

tecture, particularly in the frontal and temporal
areas and in the purkinjian layer of the cerebellum.
Blood vessel chanrres in these cases were productive
in nature, consi~ting of proliferating changes of the
intima, and hyperplasia and swelling of the intimal
endothelial cells.

It was Ferraro's opinion that

this vascular prol:Lfera tion might be related directly
to insulin intoxication, as the changes noted were
similar to those reported by other investigators as
being due to various other toxins such as lead, organismal toxemias, and infections.
In studyina the pathologic effects of metrazol,

- 107 -

Weil and Liebert (88) examined tre brains from six
patients who died two to ten months·after treatment
with this form of s1-iock therapy.

'I'l1e outstanding

features noted by them were marked hypertrophy and
hyperplasia of astrocytes and, to a lesser degree,
of trie microglia.

It is interesting to note that

t~ey found the severity of reaction to be inversely
proportional to the duration of eac~ patient's psychosis.

It has been found experimentally, however, that

the amount of pathological change 'has a positive correlation with the sum total of metrazol given throughout the course of treatment, trie duration of the treatment, and the survival period after the last injection.
This correlation,- noted by Strecker and his
co-workers (89), is apparently not always consistent,
since Arieti (90), wno also experimented with metrazol
on monkeys, found tna t the pathological changes in this:
series were not proportional to the number of convulsions,
dos&ge of the u.rug, or the duration of the seizures.
Both groups of investigators are tc•greed, however, that
in some cases no changes at all are produced in the
brain by metrazol.

Thus, the question is left open as

to what amount of brain damage can be expected after
any given course of metrazol treatments.
The evidence for central nervous system damage

I
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after electroshock treatment indicdtes that it is mainly
vascular in nature.

Experimental electroshock has been

done on rabbits and rats by rreilbru.nn and Weil (91).
Although they observed no generalized ganglion-cell
lesions or generalized proliferative glial reactions,
they noted changes in the venous system in 25 out of
their 28 cases.

Hemorrhages were present in tbe meninges

and in the substance of the brain and spinal cord.
WciS

It

found that these hemorrliages we::--e confined to the

perivascular regions of the ca:r.;il1aries, being caused
by rupture of the capillary walls.

Similarly, sub-

arachnoid and punctate hemorrhages tn the brains of
electroshocked cats were observed by Alpers and Hughes
(92).

These investigators corroborated their findings in an autopsy study (93) of two patients treated
by electroshock.

One patient dying after 62 convulsive

tree tments s11owed fresh hemorrhages in the cerebral cortex and white matter.

The brain of the other patient,

who died five months after the final treatment, showed
old areas of perivascular damage mainly in the white
matter.

Apparently t~en, the lesions produced by elec-

tros'~ock are less severe in nature than trose produced
by insulin and metrazol, since the latter two methods,
it will be recalled, caused neuron degeneration and glial

~·
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proli.fera tion.
As mentioned above, it is difficult to judge
the extent of brain damage caused by shock therapy in
any given case.

'1'11is view has been stressed by Pacella,

Barrera, and Kal inowsky ( 94), who state that "An insui'fic ient m..1..-rnber of cases have been examined pathologically, and as far as tne human material is concerned,
any examination of the brains from those dying during
or after the treatment must differentiate as to which
lesions, if found, 8re due directly to the action of
the thera:peutic me, sure, which are caused indirectly by
various somatic-physiochemical processes released by
trie t'J.erapy, and finally, which are produced by other
processes and bodily lesions playing a major role in
the lethal event.

The brain must be examined in the

light of all other post-mortem findings and conditions
in the body before any final evaluation can be made in
a given case, as the brain particira tes in many lethal
conditions the foci of which lie in the other organs
of the body. 0
Because of the lack of use of controls in
animal experimentation, because some of these investigators have employed doses higher than those used clinically, and because of the variables noted by Pacella
and his co-workers, in their analysis of human material,

- 110 one is left with the impression that the evidence for
permanent brain damage caused by

S"lOCk

therapy methods

is far from conclusive.
That changes in brain physiology occur due to
the shock therapies is evident from electroencephalo

graphic studies.

The c'hanges have been noted particularly

in the case of electroshock and have been reported ever
since t'l-\e earliest cl :tnical use of this method.

Fleming,

Golla, and Walter (95) noted, in 1969, t�at no electro
encephalograrhj_c record is obtaingble for 20 seconds af
ter the administration of the s�ock, Hnd that the elec
trical accompaniments of the convulsion itself a.re the

same as t':1ose seen during a spontaneous sei zure.

They

found that for about ten seconds a.fter the convulsion
is ended, there are few cortical potentials detectable,
but t'hen large slow waves appear over t11e wi-iole surface

of the head.

The potential rises in a:)out 3 0 seconds to

several hundred microvolts, and the waves have a fre
quency of one or two per second, wl th an irregular form,
resembling the electroencepnalogram during deep na tura.l
sleep.
They observed that this p::ene:r alized, slow dis
charge becomes progressively more regular, more rapid,
and smaller, and that a.bout 30 minutes after the end of
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the seizure, the electroencephalogram shows only waves
resembling the normal alpha rhythm in frequency and
size, al thoug'l, the area from which these arise is
larger tnan in the normal per son.
It has been found (55) t�at despite bursts
of abnormal activity in the electroencephalograms of
shock-treated patients, the pattern returns to normal
within 3 to 4 weeks after cessation o.f the treatment.
It has been stressed (80), nevertheless, that the re
versibility of these electroencephalographic changes
does not necessanily mean that brain pathology, if
present, is rever sible.
Some have raised t�e question of whether
electroshocks might initiate epilepsy.

According to

Bennett {53), it has been shown that, where electro
encephalographic studies have been made before and after
treatment, later spontaneous convulsions are not likely
to develop unless t'l,e individual is constitutionally
predisposed (already dysrhythmic).
Intellectual changes produced by the shock
therapies have been noted mainly in rep.:ard to memory
defects.
gree.

This is usually temporary and minor in de

While recovery is the rule, it has been found

in some cases to be incomplete.

Zislrind (96) has re-
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ported persistent amnesia resulting from metrazol
therapy, resembling the memory impairment noted in
organic psychos es.

In ti..e milder cases there is a

dis�irbance for isolated events of recent origin; in the
more severe cases remote memory is also affected. The
consensus of most invest igators, however, is that in the
huge majority of shock-treated cases, memory defects are
temporary.
The effect of the sliock t11erapies on men
tation and personality seerns to be a highly inconstant
phenomenon.

�umbert and Friedmann (97 ), in discussing

insulin, stated that some patients who s1'.lowed a good
social recovery appeared more euphoric, but at the same
time somewhat dull, passive, and indifferent t�an they
were before the onset of their illness.

Bennett (67)

noted personality changes suggestive of mild sensorium
defects.

Levy, Serota, and Grinker (98), in a clinical

and neurological study of 23 patients, found evidence of
disturbed cerebral function in 5096 of the patients, as
indicated in intellectual function.

Althou�h they

noted recovery in most cases within a few weeks, some
severe cases lasted as long as six months.
The lonp:-term effects on intellectual function
seem to be eithe r slight or nil in most cases.

Some
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recovering from psyc'h oses by means of the srock the
rapies are now successfully carrying out severely
intellectual positions and tasks.

Indeed, one group

of investigators (73) have gone so far as to state
that some patients, subsequent to shock therapy, dis
play a far more efficient intellectual a s well as
emotional adaptabllity to their environment than ever
before in t1-,eir lives.
Althou�h the central nervous system changes
noted above have been used by many as a cause for at
tacking the shock therapies, the hazard wriich has
aroused the most vociferous condemnations is the mat
ter of traumatic complicatlons ensuing as a result of
convulsions.
In 1939 Polatin and his co-workers (99)
shocked t!le medica l profession by announcing a ver
tebral fracture rate of 43% in a series of 51 metrazol
treated cases, with an average age of 28.7.

In the

same year, Carp (105) estimated the incidence of seri
ous extrel'l'lity fractures of hu."'11.erus or femur to have
been 1.5% to 2?<S, and dislocations 1r:i.2%.
These reports were particularly significant
in view of t�e neglect of the fracture issue in previous
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surveys of the results of convulsive therapy.

In 1936

.Meduna. had claimed (1 00) that there were no serious com
plications with the use of metrazol.

A year later, Ken

nedy {1 01 ), in reviewing results in the treatment of 1,000
patien ts, made no mention of fractures.

And in 1 939, the

same year as t'ie publication of PolHtin's dis turbing
report, Meduna and Friedman (48) listed mechanical
complicattons of convulsive s"1ock therapy without
referring
at all to vertebral fractures.
There is evidence that unsoftened convulsions
produce not only skeletal complicatlons but also trauma to
viscera.

A group of veterinarians (1 1 3) reported,

in 1 930, on findings encountered in tne viscera of cattle
and hogs in slaughter-houses, w'lich had experimentally
been given convulsive doses of electric current.
It was found on autopsy that, in addition to ver tebral
fractures and ruptures of muscles, trie re were pulmonary
congestion and petechia.1 hemorrhages thr oughout the
lungs and other viscera, indistinguishable from hemor
rhagic septicemic states.
lesions are

In all likelihood, similar

produced by unsoftened conv u.lsiv e shocks 1n the

human subject and are considered (53} to account
for the flareup of latent tuberculosis, which has been
reported (85, 1 1 4) as a danger inv olved in straight
convulsive shock therapy.
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The se rious problem of vertebral fractures and,
in extremities, fractures, dislocbtions, and ligamentous
ruptures, soon became generally recognized as one of the
greatest, if not the greatest, drawback in the use of
convulsive s�ock methods.

Indeed, in some cases these

traumatic complications were so frequent that, according
to Bennett (102), many condemned the treaonent as
inhumane and subsequently abandoned it.
The recognition of tlie high incidence of trauma
tic complict' ti.ens r:recipita. ted a general search for
methods of reducing or abolishing sucli complications
while maintainin� the beneficial therapeutic effects
derived from grand mal convulsions.

Pola.tin

and his co-workers, in their original article (99),
recommended that the patient be held in strong antero
flexion during trie convulsion.

-P-amsa and Bennett (103),

in 1939, advocated spinal anesthesia before administering
each shock.

Powever, neither of these methods gave any

constant assurance that fractures could be prevented.
In 1940, Bennett (102) introduced curare; in
the same year Rosen, Cameron, and Ziegler (104) reported
the use of beta-eryt�roidine hydrochloride.

In 1941,

Yaskin (106) advocated the use of intravenous magnesium
sulf'ate.

Two years later, Impastato and his coworkers

(107) came out in favor of sodium a.mytal.

All
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motor impulses to muscles and thereby to lessen the
severity of the convulsion.

Although any of these

chemicals are employable, the one which has gained the
widest acceptance at the present time is Bennett's
pre-convulsive curarization method.

It has the ad

vantages (108) of being specific in its action, and
non-toxic, with no side effects.

It is available in

a well-standardized preparation (Intocostrin, E. R.
Squibb and Sons) and requires only a few cubic centi
meters per injection.

Moreover, there is no question

of a central action, as is the case in the use of the
other drugs.
In 1941, Bennett (109) reported on the use
of curare in ?4 patients receiv ing 466 metrazol shocks.
In none of these did any complications occur.

Simi

larly, Cas� and �oekstra (108), in 1943, reported en
countering no traumatic complicsticns in a total of
139 patien ts receiving 995 combined curare-electro
s'hoclc treatments.

In the same year, however, Cummins

(110) noted a fracture rate of 3.9% in his series of
232 patients treated with 3,05? curare-metrazol shocks.
In his 9 cases of compression fracture occurring when
curare was used, seven showed chan�es in one vertebra
only; in the eighth case, two vertebrae were involved,
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In view of

the fracture rate of zero as reported by Bennett and
by Cash and -q-oekstra, one is led to question Cummins'
technique of curarization.
Although curarization has certainly shown
itself to be the most effective me thod of dealing with
the problem of traumatic complications, it has met ob
jections in some quarters, e. g. (56, 111), because of
supposed dangers, the usual criticism being that curare
allegedly ca.uses prolonged post-treatment apnea.

Ben

nett (53) regards these objections as being unwarranted,
since curare has no effect upon the central respiratory
mechanism; the only respiratory embarrassment which can
occur, accord.in� to him, is that due to shallow inter
costal breathing or pharyngeal muscular relaxation,
factors which can be ove�come with artificial
respiration. Also, curare possesses the advantage of'
having a specif'ic antidote -- prostigmine -- Which
adequately counteracts any excessive curare effect on
the respiratory muscles (53, 10
8 ).

Indeed, Cash and

�oekstra (108) made successful use of curare in treating
a patient whose intercostal muscles had been markedly
paralyzed by poliomyelitis.
The safety of the method is evidenced by
the fBct that by 1945 o-c;er 100,000 cura.re-metra.zol and
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curare-electroshock treatments h ad been given wit h
only one reported fatality, and in that case neither
proper artificial respiration nor prostigmine was
used (53).

According to Bennett and Cash (112), the

only contraindication to the use of curare is myasthe
nia gravis.
Tltere have been some work-era who have been
fearful of uslng shock therapy on t1,e aged.

There is

evidence, however, to indicate that this fear is un
warranted.

Evans (115) has reported the use of con

vulsive shock therapy in 50 patients who were older
than 50 years.

Of these, 40 were either recovered or

improved enough to be disc''larged, and the incidence
of complications was found to be no greater than in
younger groups.
Contraindications to the shock therapies are
not as many as might be supposed in view of the drastic
nature of the treatment.

Cardiac patients have been

treated successfully and so have those with hyperten
sion, as well as those who have reac�ed the 70-year
level or above, with circulatory systems showing evi
dence of senility and arteriosclerosis (55).

Indeed,

successful treatment in cardiac patien ts has led to
the concept that immediate treatment is imperative w'hen
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already damaged heart (56).

On the other band, some

patients hc:ve been reported as having died suddenly
from cardiovascular accidents within a few weeks after
full recovery from depressive psychoses, with the pos
sibility that the treatment may have been the causative
fact or (53).

The s�ock therapies have been administered
successfully in the presence of diabetes, pernicious
ane mia, spastic paralysis, pregnancy, hyperthyroidism,
carcinoma, coronar y disease, hypertension, and cerebral
thrombosis, without organic complications following
the course of treatment (53).

It has been noted (55)

that the anxiety and tension due to the mental dis
order may be worse physically for t'he patient than some
of these supposed contraindications.

Apparently the

only true contraindications are pulmonary or syste mic
lnfect�_ons and c1:;_rdiac decomrensation (53).
In summary, it may be said that the most
important hazards of shock therapy -- namely, skeletal
and vlsceral trauma -- can now be successfully elimi

nated by preliminary curarization of the patient, that
there is no convincing proof of significant damage to
the nervous system, and t�at definite contraindications
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One may therefore feel

justified in concluding that t''."e assets of the shock
therapies far outweigh their liabilities.

Chapter VI
The Mechanisms of
the Shock TheraEies
T his thesis being an evaluation of a par
ticuls.r type of therapy, the reader may question the
necessity of' including within it a chapter dealing
with its modus operandi.

To me, tr,e study of the

rapeutic mechanisms has distinct bearing on the
problem, since it is only by an analysis of the
manner in which a form of treatment acts that one can.
ascertain the reasons for therapeutic successes and
failures. T he question of mechanisms is there.fore one
not only of fascinating theoretic interest but also
of direct practical significance.
The disconcerting but true fact of tre mat
ter is t'l--iat the mechanisms of tte shock therapies are
at present unknown.

During the decade since the in

auguration of the s'bock methods, t11e tr:1.eories Wh. i cr
have been advanced to explain their action have been
legion, yet none of them has given a completely ac
cept1:1.bl e answer to the question.
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- 122 This is particularly interesting in the
question of the use of tre shock therapies in schizo
phrenia, for here we behold the ode spectacle of a
mystery treated with a mystery, with successful re
sults.
Sak el, the oriq:inator of insulin s:bock
therapy, was quick to recognize this bizarre state
of af.fairs.
1937,

11

"I should be glad", he stated (6) in

if it were possible to follow in this special

field the method of procedure customary in medicine,
i. e., first to investigate the cause of the malady,
and afterwards to look about for a corresponding
mode of treatment.

But once a pHth is accidentally

found which begins at the point t'hat should be the
end of the journey, shall we have the temerity to
abandon it, especially in working with a disease as
difficult as schizo1:hrenia?

And if the hypoglycemic

therapy fulf'ill.s even pa.rt of its promise, it will be
possible, I think, to reverse the usual course of in
ferences and in going backwards to learn about the na
ture and prime cause of schizophrenia."
Of course, as Barrera (80) puts it, ttrn
medicine we do not wait for a scientific explanation
if we have sometriing of therapeutic value n .

Th. e f'act

remains, however, that if we did have a scientific
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explanation, it mlght be possible to modify and im
prove the existin� met�ods of shock therapy.
words of 'P"imwich (80),

11

In the

Perhaps we a.re doing the right

thing but in a very crude way, just as if one were trying
to right a watch with a hammer.

If we could find out

the essential step in the amelioration process, then it
might be possible to accomplish it in a more direct and
less brutal fashion 11 •
This need has been felt ever since the early
days of the shock therapies.

Referring particularly to

the use of shock methods in schizophrenia, Meduna (7)
expressed his attitude on the problem in 1937.

"Beyond

all doubt, n said he, "from biolog;ical and trerapeutic
points of view, we are undertaking a violent onslaught
with either insulin or metrazol, because at present
nothing less than such a s�ock to the organism is pow
erful enough to break the chain of noxious chemical
processes that leads to schizor,hrenia.

I hope that

in the future we shall reac'h a point where it will not
be necessary to break the series of events leading to
schizophrenia. with brutal force.

Then we sha ll be able

to discard the shock and coma of the insulin treatment
and the epileptic seizure of the metrazol treatment.
Instead we shall provoke directly the slow cremical fro
ceases trat can now be stimulated on'y by the explosive
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The bulk of this thesis ras consis ted of an
analysis of facts -- statistical data.

'When conslder

ing a problem such as the mechani ams of t;.,e a"'ock the
ra1-ies, it must be realized that one is dealing in
the realm o.f theory.

Consequently, an analysis of

th1s question becomes a matter of contrasting one
opinion against another, rather than combining and
correlating clinical data.
The theories which have been advanced in
explanation of t""1e mode of action of the srock the
rapies can be divided tnto two main groups -- the
somatic and the psychic.

Let us first take up a

consideration of the former.
Sakel's original assumption (6) was that
insulin exerts its therapeutic eff0cts by a diminu
tion of the function of nerve cells.

Looking upon

a. react ion of the nervous system as a response to
stimuli, traversing certain pathways, rie explained
the processes in hypop:lyeemia by a bl )eking of pathways
previously active so that reactions to the same sti
muli run t1,,eir course over pathways p:reviously inactive.
According to Sakel's theory, there are nerve cell path-
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The higher ones are newer, more complex, and more
sensitive.

In the course of the schizophrenic pro

cess these are crippled, and the phylogenetically
older ones become dominant.

Under the influence of

insulin shock these older ones are progressively
weakened so that the cell ha. s an opportunity to re
cuperate.
As pointed out in Ch apter I, Meduna began
using convulsive shock therapy with the idea that
schizophrenia and epilepsy represent two mutually
antagoniR tic diseases and that t,.., eref ore a schj zo
pl-irenic could be cured if sub Jee ted to epileptiform
convulsions.

Of course his hypothesis of a funda

mental antagonism between the two diseases never had
any basis of proof.

In fact, on reviewing the li

terature on this point, Kennedy (50) found that spon
taneous convulsions are fairly frequent in cases of
catatonia and are by no means always followed by a
remission of symptoms.

Even if there were this an

tagonism between schizophrenia and epilepsy, how
would this explain the excellent results obtained
with convulsive therapy in non-schizophrenic condi
tions sue� as t�e affective psychoses?
By 1939 Meduna had realized the error of
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the leading investigators of' the mechanisms involved
in the shock therapies.

The crux of his present the

ory on the que:".ltion is that the s'hock therapies possess
a common factor of interference with carbohydrate me
tabolism.

It is his belief' (122) that since only a

certain group of patients benefit from hypoglycemic
treatment, despite the .fact that insulin produces the
same biochemical effects in every patient, the fact or
responsible for cure must be not the primary effect
of tre insulin but the p�tient's response to the bio
chemical effects of the hormone.

This response oc

curs about 30 minutes after the coma dose of' lnsulin
has been injected and, according to Meduna, is cha
racterized by the followinp: chanG;eS in the blood:
increaPed sugar, increased lactic acid, a slight ke
tosis, an acid shift of the. pi:r, an increase of total
fat, and a leukocytosi·s.

In other words, the response

comprises bioc'hemical changes diametrically opposite
to t'lie biological ef'fec ts of :J.nsulin.
IntereRtingly enough, Medi1na has found the
same blood changes to occur as an irmnediate response
to convulsive shock met'hods (122).

TTe points out

t""at triese chanfZes, produced by the shock therapies,
are germane to diabetes and to stim1-1lation of the

- 127 sympathico-adrenal system.

In both of these condi

tions t�ere is a shift of the equ�librium from the
vago-insulin to tre sympathico-adrenal system.

In

view of t1�e fEict that a certain proportion of' schizo
phrenics behave like diabetics in their glucose and
insulin tolerance (122, 134), Meduna regards this
observation as the mobilization of an unsuccessful
defense mechanism against the disease itself, and
that if this reaction is furthered by shock therapy
the patient I s chance-s of recovery a.re greatly en
hanced.

According to his findings, only those pa

tients recover, as a. result of insulin treatment:,
who produce an increased amount of adrenalin during
the hypo�lycemic s�ock.
Of equal interest are the biochemical chan ges
in t"':,e brain occurring: as a result of the shock thera
pies.

According to Meduna (122), studies of the cere

bral cortex reveal that alkaline strikes occur in both
the hypoglycemic and convulsive treatments.

Also, there•

is an increase in lactic acid and inorganic phosp'l,orus,
and a decrease in phosphocreatin.
The similarity of these fihdin�s to those
noted in cerebral anoxia, and the relationship be
tween anoxia and hypoglyc9mia, are matters which ap
pear to be of p;reat significance in determining the
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It has long been

known that cerebral metabolism depends upon the di
rect oxidation of p:l11c ose, and many different experi
ments have shown thet t'he oxidative processes in the
brain can be diminished equally as well by either
hypoxia or hypoglycemia (123, 124, 125}.
Gerard (123) contends that interference
w1th oxidEJ. tion in t'h.e brain leads to a secondary
11

overshooting 11 with increased activity and increased

stimulation of neurons.

Similarly, Falvorsen (124)

has found that a sudden production of anoxia has a
stimulating rebound effect on the medullary centers.
Gerard takes the view that a relatively long period
of increased respiration and activity may follow one
of interference wit"" meta.bol ism.

Fe feels that the

cause for this effect may lie in a leakage of potas
sium ions from the interior of t�e neuron during an
oxia.

At any rate, it is his belief that the s�ock

therapies obtain treir therapeutic effect not by the
primary decrease in brain metabolism, but by an in
crease in cerebral activity caused secondarily as a
rebound phenomenon following the period of cerebral
depression.

This theory appears to me to be the

cerebral equivalent of the "rebound" blood-c'bemistry
:phenomena noted by Meduna, as listed above.

- 129 1/Vhether the beneficial ef f
. ects of the shock
trerapies are directly due to the i:;rimary depression
of cerebral metabolism through hypoglycemia or hypoxia
(either of which accomplis�es the same results), or
whether it is a secondary hyperactivity of cerebral
metabolism which is the real therapeutic mechanism,
the observations noted above tend to indicate that
the shock therapies possess a common factor of caus
ing a primary interference with brain function.
Following tre recognition of anoxia as the
outstanding cliange caused by convulsive shock therapy
(126 ), attempts were made to produce this effect di
rectly, by means other than the use of metrazol or
elec tros,..,ock.

Bot'l-i nitrogen inhalation (127, 128) and

the breathing of air containing a low percentage of
oxygen (129) have been tried.

The former method was

experimented on in the days of unsoftened metrazol
metrazol convulsions, wl,en it was desired to achieve a
met'!:od of convulsive tl-ierapy lacking the undesirable
traumatic effects of metrazol.

As was pointed out in

the preceding chapter, the objections to metrazol or
electroshock therapy on the bas is of trauma. tic compli
ce1 tions are no longer W<''irranted since the introduction
of the use of preliminary curarization.

Not enough

investigation has yet been carried out along the line

of inducing anoxia by the inhalation of low-tension
oxygen to warrant an opinion as to the efficacy of
th-i s method.

It may be noted, however, that its use

in ten patients (129) produced no significa nt changes,
either beneficial or detrimental.
If one accepts the theory that the
therapeutic effects of the shock therapies are due
entirely to the production of chan�es in metabolism,
one must immediately realize that this viewpoint
leaves unanswered the question o.f the psychological
mechanisms involved.

Th.at somatic factors are far

from being the only ones operating in producing cures
is evidenced by the observation, noted in previous
cha pters, that patients who have had a course of shock
treatment supplemented with psychot,.,erapy have
consietently enjoyed better and lon�er-lasti ng
recoveries than those who have had shock therapy

alone.
It should be realized at t�e outset of our
discussion of the psycr i c mechanisms involved in the
s,.,_,ock therapies t1--ia t here we must necessarily enter

into t½e realm of speculation.

Many ')f t'te views on

this phase of the �uestion are f illed with much

dramat1-c content, t'..,e reliabllity of which is a
matter for individual surmisal.

- 131 Alt�ough Sakel, it will be recalled, pro
posed an explanation of the effects of insulin the
rapy on a basis of changes in neural physiology, he
did not neglect to include a. psycrtc component in his
hypothesis.

Pe assumed (6) that hypoglycemia abolishes

and subdues principally the parts of the psychic life
which have been most active.

Trius, according to his

t�eory, it pe rmits t�e other antagonistic part to reach
t�e surface and to attain a dominance.
"In cases �h ich r un a favorable course,"
he stated (6), "hypoglycemia., frequently and correctly
induced, leads to a rermanent restoration of previously
sup?ressed rsychic components.

At the same time those

that were previously active are weakened and submerged.
vypoglycemia apparently breaks the path.ological mental
pathways and cuts off the 'short circuits'.

In this way,

the passing of impulses across to an inappropriate
pat�1way is prevented; wit;, furti,er uee of 1-typoglycemia,
the short circuits are more and more fenced off and
isolated.

Eventually every stimulus starts an impulse

over the proper patrway only. 11
Meduna likewise, although he is convinced of
a large biochemical ftl.ctor in the mechanisms of the shock
t�erapies, as pointed out above, does not negl ect the
a dmission of psyc',,olog1cal for ces.

tris theory is psycho-

- 132 analytic in nature, for he believes (134) that the
slow ly progressive physiological decerebration of the
patient durini;r, insulin treatment produces a regression
of the personality to so low a level that the psychi
atrist is invested with qualities reculiar to the
fat•,..,er of the patient.

According to his tlieo ry, this

slow regression permits a transference, w �ich is later
utilized in subsequent psychotherapy.
Jessner and Ryan (3d) feel that hypoglycemia
changes the organism in such a way that the patient
becomes able to turn his affection and his interest to
persons and objects of the outside world and so to
give up �is narcissistic isolation.

They believe that

whet'l-;er tnis altered attitude is merely temporary or
becomes permanent depends greatly upon his capacity
nto endure reality, with its a.llurinp: and threatening
qua.lities. 11
There have been many workers who, in con
trast to Sakel and Meduna, have discarded any physi
cal explanation of the shock t'herapies and have built
up hypotheses in which the effect of therapy on the
patient's psyche is regarded as the sole factor in
operation.

Such a viewpoint has been taken, for

example, by Gottlieb and uuston (19), w ho, as noted
in

- 133 Chapter II, found no difference in recovery rate be
twee n a _n insulin-treated group of schizophrenics and
a control group who "1a d had no shock therapy but who

ha d been subjected to intensive p s ychotherapy, includ
ing re-conditioning through socia liza tion programs.
The similarity of re::mlts obta ined suggested to
Gottlieb a nd �uston a corn.�on fa ctor in the two methods
a tment.
of tre

This fa ctor they a ssumed to be

t'l-ie pressure toward socializa tion w}1ich wa s being exerted
consta ntly on the patients from severa l directions.
T:hey felt that the insulln trea tment could be t�oug'ht of
as one method of exerting such pressure, especially

through the a ttention the pa tient receives
in experiencing the coma .

Gottlieb a nd i::ruston there

fore c oncluded tha t shock treatment 0a n certainly not

be considered a specific t1-,era py for schizophrenia.
Of course ti,,is conclusion ls not unique, since,
a s will be recalled from previous chapters, it has re
pea tedly been observed tha t pati ents who ha ve been sub
jected to a

therapeutic program in w'bich s'h ock therapy is

only one of ma ny items, fare muci, better than triose who
receive shock alone.

One must therefore search

for the mecha nisms whereby shock thera py makes the
patient a more favorab Le subject for psyc11otherapy.
Lowenbach and Stainbrook (133) have stressed
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the view that each shock treatment leaves a human
being in a state in which all that is called the
Following the

personality �as been extinguished.

convulsion, according to them, the return of the
hig'-'\ er functions is accompanied by a re-integration of
t�e personality.

These writers neglect, however, to

consider the psychological mechanlsms whereby the reintegration takes place.
Shapiro and Freeman (83) feel that the
temporary impairment of cerebration, caused by the
anoxia which is produced by the shock therapies, is
the significant factor in operation.

Concerning the

effects of this phenomenon, particu::.arly in dealing w1
th the neuroses, t1-:ey contend that when consecutive
thoug'1t is impossible, individuals are no longer ca
pable of cogitation and ru::nination, and the perplexity
and anxiety induced by failure to :f"fnd a solution to
t1"eir problems tend to disappear.

In other words, a

relief cf tension is produced.
In regard to the affectiv e psychoses, the
consensus seems to be that the srock therapies operate
by producing a release of affective energy.

Flescher

(130) holds that shock represents a means of conveying
huge amounts of ener�y inherent to the death and de
structive drives, thereby unloading them in an indivi-

dually and socially harmless manner.
According to Levy and Grinker (8 1), the
physiolo�ic disturbances in the brain produced by
convuls ive sl,ock treatment affect tre dynamic rela
tions between tne inribiti.np:, repressin� functions and
the inhibited, repressed, aggressive drives, resulting
in a freer expression of these affects more directly
in dream, fantasy, or verbal or motor activity.

These

aut½ors note th8t ti-ie liberation of aggressive drives
need not be accompanied by conscious intellectual
awareness of the process, since they may appear in
rationalized or projected form or as increased self
assertiveness or aggressiveness.

Apparently, then,

the effect of subsequent psychotherapy is to add
emotional insigh,t and intellectual under standing of
the psycnic conflict, after the release of feeling
obtained by s',,-,ock.
·what is t"he meaning of shock treatment for
t'!-ie ratient?

Tl-ie only direct means of determining

this is by noting the thoughts expressed by patien ts
after regaining consciousness following a shock treat
ment.

One said (77),

"What have you done to me?

feel as though I'm reborn!"

I

Others have made state

ments such as the following { 64): "I've come to life n ;

- 136 -

"Where am I?
11

Tr:iings are all changed,

more natural";

I am younger again"; and so on.
It has been noted (77) that some patien ts

react to shock treatment as a form of physical
punishment, just as they may react to
psychotherapeutic sessions as scoldin�s.

This

appears to be the case with electroshock just as it was
with. metrazol, for although the former does not produce
the horrifying feeling of dissolution and impending
death which is one of the main disadvantages of
metrazol (55), still it appears that electroshock does
cause a vague fear of the treatment,

at eit�er an

unconscious or conscious level (?7).
Selinski (77) has proposed an interesting hypothesis as
to t1,-,e nature o.f this sense of fear.
In my opinion," he states, "shock treatment affects
the psyche of the patient as a profound threat to his
very existence. It reaches down to something rrimi11

tive

we can call it the instinct for self-preserve.

tion

or ego instincts -- or w�at you will -- in the

human organism.

Certainly it is a fact that tl-iey re

gard the loss of consciousness resulting from the
treatment with dread; t1--,ey feel that they must com
pletely surrender th,emselves to the mercy of others
as one undergoing general anesti--.esia.

The same doubt

as to whether they will emerge alive is operative in
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shock t herapy.

Significantly, a common reaction is

to find early disappearance of suicidal impulses
among the psycho-pathologic phenomena of the patient's
mental disorder.

One may speak of a re-integration

of ego structure made possible by a violent shock to the
p8rsonality.

The benefit derived from shock therapy

seems to stem from psycho-physiological alterations
whicl-i stimulate the individual's will to live and
reduces the wit...,drawal tendency. 11
That shock treatment represents a punishment,
a threat to existence, and, following the regaining of
consciousness, a rebirth, has been emphasized by a
number of different writers (64, 81, 119,
131, 132).

This is particularly significant

in the

depressive psychoses, since here t�e demand of the
conscience for punishment and death represents the
paramount aspect of the psychosis.

As Bennett (64) puts

it, n'A'aving undergone the painf'ul convulsive therapy, the
patien t has approached death psychologically, has
suffered punishment, and bas, as it were, proved 'himself
will:lng to take punis'l--ment.

His conscience is then

freed; and he can allow himself to start lire over ap;ain
free from the compulsive pangs
of conscience."
If the psychological factors noted above

- 138 represent the true psychic mechanisms whereby
convulsive shock therapy acts, then possibly we
have an explanation of the more favorable effect or
the treatment on the affective disorderR than on
schizophrenia, except in t1--iose schizophrenics who
exhibit affective components in their psychosis.

In

other sc½izuphrenlcs, apparently, improvement occurs
only in so far as their t1-iought disorders are the
consequence or inhibition.

This latter view (50)

has been substantiated by the use of tl-ie Rorschach
test (11), in w1-,1ch it was found that those
schizophrenic patients wro benefited from convulsive
treatment proved to be more emotionally inhibited,
more psychically constricted, and more socially
witrdrawn than those who did not.
Even with all these interesting observa
tions, there are still some significant questions,
regarding the mechanisms of the s'hock therapies,
w�ich remain unanswered.

Since, in the somatic sphere,

it �as been srown that the same p�ysiological distur
bances are prodvced by both the hypogly cemic and the
convulsive methods, why should not all cases respond
equally as well to one form of treatment as to the
other?
re-

Or, on the othe r ha.nd, if improvement and
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covery are brought about by psychic mechanisms rather
than by metabolic changes, what is there about the
psychological response to hypoglycemic therapy which
makes some forms of schizophrenia yield to it more
easily than to convulsive methods?
The status of our present understanding of
the mec•,anisms of t'-le shock t1-ierapies is best summar
ized by M'liller's statement {1�5):

"Neither the endo

crj_ne phase of t'l--ie treatment, nor bra.in pat"1ology, nor
the q_ue::,tion of convulslons, nor the soothing, quieting
effect, nor failing consciousness, nor the potent
psycl:ic shock is alone sufficient to solve our problem."
My own pe rsonal feeling concerning these
heuristic questions is that future tnvestigation will
probably not only reveal the answers but will also
lead to a greater understanding of the nature of mental
diseases.

There is already much evldence (134) to

indic2te that there is a large somatic factor in
schizophrenia,

in tr.e form of a dysfunctioning of the

endocrine system,

and that t·here is a great degree of

:interaction between mental and physical forces in
mental diseases in �eneral.

- 140 With triis in mind, and wlth the observation,
in other branches of medicine, that an increasing un
derstanding of the nature of so-called ttorganic tr dis
eases has led to an emphasis on their "functional"
aspects,

one realizes l-iow closely psychie.try and the

non-psychiatric fields of medicine are now approaching
each other.
We are slowly beginning to recover from the
damage wrought to our conception of disease by Galen
and by Virchow, and we are now returning to the wis
dom of the 'P'ippocratic concept of' tre human being,
a two-thousand-year old concept W'hich has recently
been dubbed with the misnomer
cine".

11

Psychosomatic Medi

I call this appellation a misnomer since it

implies a dualism which does not_ exist, and therefore
belies the very idea which it seeks to describe. To me,
the 'P'ippocra.tic concept represents the study of the
individual not as a combination of :r;sycric
and somatic elements, but as one d;y munic unit in which
psyche and soma are fused.

J:f I were to coin

a name for this neo-uippocratism, : should call it nun
i tary Medicine 11•
In investi�ating the role of the shock
therapies in psychiatry. I have beon amazed at t1,e
enormous number of ramifications of the problems

- 141 raised by th.eir use.

Over and above tre .fa.ct that

they have revitalized the whole field of psychiatry
with a renewed interest and have dispelled the de
featism of former days, they have provided an impetus
to many fields of research, including biochemistry,
pharmacology, physiology, pati,ology, psychology, and
clinical medicine.

All of which is an example of the

fact that the full significance of any new advance in
medicine cannot be foreseen at the time of its dis
covery.
Medical progress is a c1.unulative phenomenon,
and no one generation can '1ope to reech t'he solution
of all of medicine 1 s problems.

V'Jhat eac1, medical

generation can a.ccomplis"r however, it seems to me,
is to increase and to enric" the heritage which it
has received from the past.

Unanswered problems thus

become not a matter for regret, but a stimulus for
continuous and diligent investigation.
As Foster Kennedy {136) has put it, "We are
now only picking at the locks of doors behind which
lie the answers to these mysteries.

Many keys will

be needed for t,,.,e opening, but it s11rely will not be
beyond man's wit to make them."

Summary
1.

The shock therapies, inaugurated a. de

cade ago as innovations in psychiatric treatment, have
now become major weapons in the armamentarium of the
psychiatrist and have been used widely enough and long
enough to permit a rational appraisal of their merits
and shortcomings.
2.

Because of lack of unlformity in the

reporting of results and because of' the many and com
plex varie.bles to be taken into account within the
schizophrenic disease-process, the value of the shock
therapies in this disease is difficult to assess with
certainty or finality.

At the present time it can be

said that the therapies have proved useful in facilitat
ing and ace elerating the reco,reries of schizophrenics
and that the benefits to be derived from them vary from
one patient to another and are in direct proportion to
the prognosis of each case if left untreated and to the
duration of the psychosis.
3.

Of the two forms of therapy, the hypo

glycemic method has proved itself to possess more general
- 142 -

- 143 userulness in schizophrenia than has the convulsive
type of treatment.

The latter has shown itself to be

of greatest value in catatonic schizophrenia and in
sc�izophrenic cases where there is an affective com
ponent in the clinical picture.

There is evidence to

indicate that convulsive therapy, when used intensively,
is possible of effecting responses as favorable as those
which have been ace omplished with the use of insulin.
Enough statistical data has been accumulated to indicate
a. high probability that t"ie latter method has produced
almost twice as many sustained recoveries as occur in
non-shock-treated cases.
4.

In the affective psychoses, the shock

therapi.es have broua:h t about uniformly gratifying rates
of recovery and improvement, irrespective of the duration
of illness.

Depressives respond better th.an manics, and

involutional melancholiacs better than involutional para
noids.

Convulsive shock therapy has found its greatest

sphere of usef'ulness in triese psychoses, the method of
choice today being electroshock, bec•n:tse of its ma rked
advantages over metrazol.
5.

T11e shock therapies have proved of little

value in the psychoneuroses, except in war neuroses,
psychoneurotic depressions, obsessive-compulsive and

- 144 hysterical states, and in borderline states between
the neuroses a nd the psychoses.
6.

Best resulta from the shock therapies

are obtained when they a re supplemented with other
forms of trea tment, particularly psyc"hotherapy.
7.

Bodily damage produced by the use of

t�e shock thera pies is now negligible, since the intro
duction of methods, notably curarization, by which con
vulsions a re softened.

The treatments ca n be given in

the presence of' a host of orga nic diseases a nd a.re
contraindicated only in the existence of pulmona ry or
systemic infections or of cardiac decompensation.
8.

Tl-1e modus opera ndi of the shock therapies

is not definitely known at the presert time.

There is

evidence to show that the therapies possess a common
factor of interfering with cerebral meta bolism either
throu�'11. a noxia or hypoglycemia .

Ma ny theo-r ies have

been advanced to explain the mode of action on the
It is quite

basis of subconscious psychic alterations.
likely t�at future resea rch concer ning the

mechanisms of the shock therapies ma y brin� forth
findings which will lead to a greater understa nding
of the diseases treated by them.

*

*

*

I
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Before terminating this analysis of the
si,.,ock therapies in psychiatry, I should like to con
clude with a statement by Katzenelbogen (38).

It is

a thought which in my opinion contains a truth
profound enough to be used as a guiding motto 1n the
practice of: any field of medicine:
"The success of shock therapy, as that of
any other therapeutic procedure, depends much more
upon enlightened individualization than upon hard and
fast rules supposedly applicable to all cases. 11
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